Abstract
The role of the monoamines, norepinephrine (NE), dopamine (DA), and serotoin (5-HT), has been evaluated across numerous behavioral situations, ranging from apparently simple response patterns, e.g., locomotor activity, to complex ones involving associations between stimulus events and response consequences. Not surprisingly, theorizing concerning the relations between monoamines and behavior has extended beyond models involving infrahuman animals, and has been employed to account for a variety of aberrant human behaviors.
Research supported by Grants A8267 and A8945 from the National Research Council of Canada to Bruce A. Pappas and Hymie Anisman, respectively. David A. V. Peters is a holder of an Ontario Mental Health Scholarship.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian, G. K., 1972, Chemical feedback regulation of serotonin-containing neurons in brain, Ann. N.Y. Acad. Sci. 193: 86–94.
Aghajanian, G. K., and Gallager, D. W., 1975, Raphe origin of serotonergic neurons terminating in the cerebral ventricles, Brain Res. 88: 221–231.
Aghajanian, G. K., and Haigler, H. J., 1975, Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors, Psychopharmacology 1: 619–629
Aghajanian, G. K., Bloom, F. E., and Sheard, M. H., 1969, Electron microscopy of degeneration within the serotonin pathway of rat brain, Brain Res. 13: 266–273.
Aghajanian, G. K., Haigler, H. J., and Bloom, F. E., 1972, Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons in rat brain, Life Sci. 11: 615–622.
Ahlenius, S., 1973, Inhibition of catecholamine synthesis and conditioned avoidance acquisition, Pharmacol. Biochem. Behay. 1: 347–350.
Ahlenius, S., 1974, Effects of L-dopa on conditioned avoidance responding after behavioral suppression by a-methyltyrosine or reserpine in mice, Neuropharmacology 13: 729–739.
Ahlenius, S., and Engel, J., 1971, Behavioural and biochemical effects of L-DOPA after inhibition of dopamine-ß-hydroxylase in reserpine pretreated rats, Naunyn Schmiedelherg’s Arch. Pharmacol. 270: 349–360.
Ahlenius, S., and Engel, J., 1974, Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-ß-hydrosylase inhibitor, J. Neural Transm. 34: 267–277.
Ahlenius, S., and Engel, J., 1975, Antagonism by haloperidol of the L-dopa-induced disruption of a successive discrimination in the rat. J. Neural. Transm. 36: 43–49.
Ahlenius, S., Carlsson, A., and Engel, J., 1975, Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat, J. Neural. Trans. 36: 327–333.
Alexander, G. J., Kopeloff, L. M., and Alexander, R. B., 1971, Anticonvulsive effect of pchlorophenylalanine in audiosensitive mice, Life Sci. 10 (1): 877–882.
Allen, C., Allen, B. S., and Rake, A. V., 1974, Pharmacological distinctions between “active” and “passive” avoidance memory formation shown by manipulation of biogenic amine active compounds, Psychopharmacologia 34: 1–10.
Alpers, H. S., and Shore, P. A., 1969, Specific binding of reserpine —association with norepinephrine depletion, Biochem. Pharmacol. 18: 1363–1372.
Amaral, D. G., and Foss, J. A., 1975, Locus coeruleus lesions and learning, Science 188: 377–378.
Anden, N. E., Dahlstrom, A., Fuxe, K., Larsson, K., and Ungerstedt, U., 1966, Ascending monoamine neurons to the telecephalon and diencephalon, Acta Physiol. Scantl. 67: 313326.
Anden, N. E., Corrodi, H., Fuxe, K., and Hökfelt, T., 1968, Evidence for a central 5hydroxytryptamine receptor stimulation by lysergic acid diethylamide, Br. J. Pharmacol. Chemother. 34: 1–7.
Anden, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., and Ungerstedt, U., 1970, Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur.J. Pharmacol. 11: 303–314.
Anden, N., Strombom, U., and Svensson, T. H., 1973, Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity, Psychopharmacologia 29: 289–298.
Angeletti, P. V., 1971, Chemical sympathectomy in newborn animals, Neuropharmacology 10: 55–59.
Anisman, H., 1975a, Time dependent variations in aversively motivated behaviors: Nonassociative effects of cholinergic and catecholaminergic activity, Psychol. Rev. 82: 359–385.
Anisman, H., 1975b, Differential effects of scopolamine and d-amphetamine on avoidance: Strain interactions, Pharmacol. Biochem. Behay. 3: 809–817.
Anisman, H., 1975c, Effects of scopolamine and d-amphetamine on one-way shuttle and inhibitory avoidance: A diallel analysis in mice, Pharmacol. Biochem. Behay. 3: 1037–1042.
Anisman, H., 1975d, Acquisition and reversal learning of an active avoidance response in three strains of mice, Behay. Biol. 14: 51–58.
Anisman, H., 1976, Effects of scopolamine and d-amphetamine on locomotor activity before and after shock: A diallel analysis in mice, Psychopharmacology 48: 165–173.
Anisman, H., and Cygan, D., 1975, Central effects of scopolamine and d-amphetamine on locomotor activity: Interaction with strain and stress variables, Neuropharmacology 14: 835–840.
Anisman, H., and Kokkinidis, L., 1974, Effects of central and peripheral adrenergic and cholinergic modification on time dependent processes in avoidance performance, Behay. Biol. 10: 161–171.
Anisman, H., and Kokkinidis, L., 1975, Effects of scopolamine, d-amphetamine and other drugs affecting catecholamines on spontaneous alternation and locomotor activity in mice, Psychopharmacologia 45: 55–64.
Anisman, H., and Waller, T. G., 1971, Effects of methamphetamine and shock duration during inescapable shock exposure on subsequent active and passive avoidance,,. Comp. Physiol. Psychol. 77: 143–151.
Anisman, H., Wahlsten, D., and Kokkinidis, L., 1975, Effects of d-amphetamine and scopolamine on activity before and after shock in three mouse strains, Pharmacol. Biochem. Behay. 3: 819–824.
Anisman, H., Kokkinidis, L., Glazier, S., and Remington, G., 1976, Differentiation of response biases elicited by scopolamine and d-amphetamine: Effects on habituation, Behay. Biol. 18: 401–417.
Anlezark, G. H., Crow, T. J., and Greenway, A. P., 1973, Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesion, Science 181: 682–684.
Aprison, M. H., and Hingtgen, J. N., 1966, Neurochemical correlates of behavior. V. Differential effects of drugs on approach and avoidance behavior in rats with related changes in brain serotonin and norepinephrine, Recent Adv. Biol. Psychiatry 8: 87–100.
Aprison, M. H., and Hingtgen, J. N., 1969, Brain acetylcholine and excitation in avoidance behavior, Biol. Psychiat. 1: 87–89.
Aprison, M. H., and Hingtgen, J. N., 1970, Evidence of a central cholinergic mechanism functioning during drug-induced excitation in avoidance behavior, in “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), pp. 543–560, Forsvarets Forskning-Sansalt, Stockholm.
Aprison, M. H., Hingtgen, J. N., and McBride, W. J., 1975, Serotonergic and cholinergic mechanisms during disruption of approach and avoidance behavior, Fed. Proc. Fed. Am. Soc. Exp. Biol. 34: 1813–1822.
Asher, I. M., and Aghajanian, G. K., 1974, 6-hydroxydopamine lesions of olfactory tubercles and caudate nuclei: Effect on amphetamine-induced stereotyped behaviour in rats, Brain Res. 82: 1–12.
Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1973, Inhibition of adrenal dopamine-ßhydroxylase by 6-hydroxydopamine, Biochem. Pharmacol. 22: 2581–2589.
Axelrod, J., and Tomchick, R., 1958, Enzymatic O-methylation of epinephrine and other catechols, J. Biol. Chem. 233: 702–705.
Azzaro, A. J., and Rutledge, C. O., 1973, Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain, Biochem. Pharmacol. 22: 2801–2813.
Baldessarini, R. J., and Kopin, I. J., 1967, The effect of drugs on the release of norepinephrine-H3 from central nervous system tissues by electrical stimulation in vitro, J. Pharmacol. Exp. Ther. 156: 31–38.
Baldessarini, R. J., and Griffith, F. F., 1976, Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat, Psychopharmacology 48: 91–95.
Banerjee, U., and Lin, G. S., 1973, On the mechanism of central action of amphetamine: The role of catecholamines, Neuropharmacology 12: 917–931.
Barrett, R. J., and Steranka, L. R., 1974, Analysis of d-amphetamine produced facilitation of avoidance acquisition in rats and performance changes subsequent to drug termination, Life Sci. 14: 163–180.
Barrett, R. J., Leith, N. J., and Ray, O. S., 1973, A behavioral and pharmacological analysis of the variables mediating active avoidance behavior in rats, J. Comp. Physiol. Psychol. 82: 489–500.
Barrett, R. J., Leith, N. J., and Ray, O. S., 1974, An analysis of the facilitation of avoidance acquisition produced by d-amphetamine and scopolamine, Behay. Biol. 11: 189–205.
Barry, III, H., Steenberg, M. L., Manian, A. A., and Buckley, J. P., 1974, Effects of chlorpromazine and three metabolites on behavioral responses in rats, Psychopharmacologia 34: 351–360.
Bartholini, G., and Pletscher, A., 1968, Cerebral accumulation and metabolism of C“-DOPA after selective inhibition of peripheral decarboxylase, J. Pharmacol. Exp. Ther. 161: 1420.
Baumgarten, H. G., Björklund, A., Lachenmayer, L., Nobin, A., and Stenevi, U., 1971, Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine, Acta Physiol. Scand. Suppl. 373: 1–15.
Baumgarten, H. G., Evetts, K. D., Holman, R. B., Iversen, L. L., Vogt, M., and Wilson, G., 1972, Effects of 5,6-dihydroxytryptamine on monoaminergic neurons in the central nervous system of the rat, J. Neurochem. 19: 1587–1597.
Baumgarten, H. G., Björklund, A., Lachenmayer, L., and Nobin, A., 1973, Evaluation of the effects of 5,7-dyhydroxytryptamine on serotonin and catecholamine neurons in the rat CNS, Acta Physiol. Scand. Suppl. 391: 1–22.
Beaton, J. M., LeBlanc, A. E., and Webster, C. D., 1974, The effects of d-amphetamine on the interresponse times of rats and guinea pigs on a modified Sidman discriminated avoidance schedule, Psychopharmacologia 37: 199–203.
Beer, B., and Lenard, L. G., 1975, Differential effects of intraventricular administration of 6hydroxydopamine on behavior of rats in approach and avoidance procedures: Reversal of avoidance decrements by diazepam, Pharmacol. Biochem. Behay. 3: 879–886.
Bennett, J. L., and Aghajanian, G. K., 1975, D-LSD binding to brain homogenates: Possible relationship to serotonin receptors, Life Sci. 15: 1935–1944.
Bennett, J. L., and Aghajanian, G. K., 1976, Response of single raphe neurons to (+)-LSD: Correlation with (+)-LSD binding in brain, J. Pharm. Pharmacol. 28: 516–518.
Bertler, A., Hillarp, N. A., and Rosengren, E., 1960, “Bound” and “free” catecholamines in the brain, Acta Physiol. Scand. 50:113–118.
Besson, M. J., Cheramy, A., Feltz, P., and Glowinski, J., 1969, Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat, Proc. Nat. Arad. Sci. C.S.A. 62: 741–748.
Björklund, A., Nobin, A., and Stenevi, U., 1973a, The use of neurotoxic dihydroxytryptamines as tools for morphological studies and localized lesioning on central indoleamine neurons, Z. Zellforsch. 145: 479–501.
Björklund, A., Nobin, A., and Stenevi, U., 1973b, Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine, Brain Res. 50: 214–220.
Björklund, A., Baumgarten, H. G., and Rensch, A., 1975, 5,7-Dihydroxytryptamine: Improvement of its selectivity for serotonin neurons in the CNS by pre-treatment with desipramine, J. Neurochem. 24: 833–835.
Bonnay, M. M., Guirinol, F., and Bohuon, C. J., 1974, Evidence for a peripheral effect of fusaric acid, a dopamine-ß-hydroxylase inhibitor on serotonin metabolism, Biochem. Pharmacol. 23: 2770–2773.
Borbely, A. A., Huston, J. P., and Waser, P. G., 1973, Physiological and behavioral effects of parachlorophenylalanine in the rat, Psychopharmacologia 31: 131–142.
Bolles, R. C., 1970, Species-specific defense reactions and avoidance learning, Psychol. Rev. 77: 32–48.
Bovet, D., Robustelli, F., and Bignami, G., 1965, Étude du conditionnement inhibiteur chez le rat. Action de l’amphétamine, de la chlorpromazine et des agents cholinergiques, C. R. Acad. Sci. 260: 4641.
Braestrup, C., and Nielsen, M., 1975, Intra-and extraneuronal formation of the two major noradrenaline metabolities in the CNS of rats, J. Pharm. Pharmacol. 27: 413–419.
Bradley, P. B., and Briggs, I., 1974, Further studies on the mode of action of psychotomimetic drugs: Antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine, Br. J. Pharmacol. 50: 345–354.
Brawley, P., and Duffield, J. C., 1972, The pharmacology of hallucinogens, Pharmacol. Rev. 24: 31–66.
Breese, G. R., 1975, Chemical and immuno chemical lesions by specific neurotoxic substances and antisera, in “Handbook of Psychopharmacology” (L. L. Iverson, S. D. Iverson, and S. H. Snyder, eds.), Vol. I, pp. 137–189, Plenum Press, New York.
Breese, G. R., and Cooper, B. R., 1975, Behavioral and biochemical interactions of 5,7dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats, Brain Res. 98: 517–527.
Breese, G. R., and Howard, J. L., 1971, Effect of central catecholamine alterations on the hypothermic response to 6-hydroxydopamine in desipramine treated rats, Br. J. Pharmacol. 43: 671–674.
Breese, G. R., Howard, J. L., and Leahy, J. P., 1971, Effect of 6-hydroxydopamine on electrical self-stimulation of the brain, Br. J. Pharmacol. 43: 255–257.
Breese, G. R., Cooper, B. R., Grant, L. D., and Smith, R. D., 1974a, Biochemical and behavioral alterations following 5,6-dihydroxytryptamine administration into brain, Neuropharmacology 13: 177–187.
Breese, G. R., Cooper, B. R., and Mueller, R. A., 1974b, Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine, Br. J. Pharmacol. 52: 307–314
Broch, O. J., and Fonnum, F., 1972, The regional and subcellular distribution of catechol-O-methyl transferase in the rat brain, J. Neurochem. 19: 2049–2055.
Brodie, B. B., Tomich, E. G., Kuntzman, R., and Shore, P. A., 1957, The mechanism of action of reserpine: Effect of reserpine on capacity of tissue to bind serotonin, J. Pharmacol. Exp. Ther. 119: 461–467.
Brody, J. F., 1970, Behavioral effects of serotonin depletion and of p-chlorophenylalanine (a serotonin depletor) in rats, Psychopharmacologia 17: 14–33.
Brownstein, M., Saavedra, J. M., and Palkovits, M., 1974, Norepinephrine and dopamine in the limbic system of the rat, Brain Res. 79: 431–436.
Brownstein, M. J., Palkovits, M., Saavedra, J. M., and Kizer, J. S., 1975, Tryptophan hydroxylase in the rat brain, Brain Res. 97: 163–166.
Butcher, L. L., and Engel, J., 1969, Behavioral and biochemical effects of L-DOPA after peripheral decarboxylase inhibition, Brain Res. 15: 233–242.
Butcher, L. L., Engel, J., and Fuxe, K., 1972, Behavioral, biochemical and histochemical analysis of the central effects of monoamine precursors after peripheral decarboxylase inhibition, Brain Res. 41: 387–411.
Buus-Lassen, J., 1974, The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction, Psychopharmacologia 34: 243–254.
Carew, T. J., 1970, Do passive avoidance tasks permit assessment of retrograde amnesia in rats?, J. Comp. Physiol. Psychol. 72: 267–271.
Campbell, J. C., and Seiden, L. S., 1973, Performance influence on the development of tolerance to amphetamine, Pharmacol. Biochem. Behay. 1: 703–708.
Carlsson, A., 1970, Amphetamine and brain catecholamines, in “Amphetamines and Related Compounds” (E. Costa and S. Garattini, eds.), pp. 289–300, Raven Press, New York.
Carlsson, A., and Waldeck, B., 1964, A method for fluorimetric determination of 3-methoxytyramine in tissues and the occurrance of this amine in brain, Scand. J. Clin. Lab. Invest. 16: 133–138.
Carlsson, A., Rosengren, E., Bertler, A., and Nilsson, J., 1957, Effect of reserpine on the metabolism of catecholamines, in “Psychotropic Drugs” (S. Garattini and V. Ghetti, eds.), pp. 363–372, Elsevier. Amsterdam.
Carlsson, A., Corrodi, H., Fuxe, K., and Hökfelt, T., 1969a, Effect of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4, adimethyl-meta-tyramine, Eur. J. Pharmacol. 5: 367–373.
Carlsson, A., Corrodi, H., Fuxe, K., and Hökfelt, T., 1969b, Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyla-ethyl-meta-tyramine, Eur. J. Pharmacol. 5: 357–366.
Carey, R. J., and Kritkansky, R. P., 1972, Absence of a response-rate-dependent effect of d-amphetamine on a DRL schedule when reinforcement is signalled, Psychon. Sci. 26: 285–286.
Carlton, P. L., and Advokat, C., 1973, Attenuated habituation due to parachlorophenylalanine, Pharmacol. Biochem. Behay. 1: 657–663.
Carlton, P. L., and Wolgin, D. L., 1971, Contingent tolerance to the anorexigenic effects of amphetamine, Physiol. Behay. 7: 221–223.
Castellano, C., Sansone, M., Renzi, P., and Annecker, L., 1973, Central stimulant drugs on avoidance behaviour in hamsters, Pharmacol. Res. Commun. 5: 287–293.
Cerletti, A., and Rothlin, E., 1955, Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives, Nature (London) 176: 785–786.
Chalmers, J. P., Baldessarini, R. J., and Wurtman, R. J., 1971, Effects of 1-dopa on norepinephrine metabolism in the brain, Proc. Nat. Acad. Sci. U.S.A. 68: 662–666.
Chase, T. N., Breese, G. R., and Kopin, I. J., 1967, Serotonin release from brain slices by electrical stimulation: Regional differences and effect of LSD, Science 157: 1461–1463.
Ciaranello, R. D., Barchas, R. E., Byers, G. S., Stemmle, D. W., and Barchas, J. D., 1969, Enzymatic synthesis of adrenaline in mammalian brain, Nature (London) 221: 368–369
Cicero, T. J., Sharpe, L. G., Robins, E., and Grote, S. S., 1972, Regional distribution of tyrosine hydroxylase in rat brain, J. Neurochem. 19: 2241–2243.
Clineschmidt, B. V., and Lotti, V. J., 1974, Indoleamine antagonists: Relative potencies as inhibitors of tryptamine and 5-hydroxytryptamine-evoked responses, Br. J. Pharmacol. 50: 311–313.
Colburn, R. W., Goodwin, F. K., Murphy, D. L., Bunney, W. E., and Davis, J. M., 1968, Quantitative studies of norepinephrine uptake by synaptosomes, Biochem. Pharmacol. 17: 957–964.
Conner, R. L., Stolk, J. M., Barchas, J. D., and Levine, S., 1970, Parachlorophenylalanine and habituation to repetitive auditory startle stimuli in rats, Physiol. Behay. 5: 1215–1219.
Cooper, B. R., Breese, G. R., Howard, J. L., and Grant, L. D., 1972a, Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquisition, Physiol. Behay. 9: 727–731.
Cooper, B. R., Breese, G. R., Howard, J. L., and Grant, L. D., 1972b, Enhanced behavioral depressant effects of reserpine and a-methyl-tyrosine after 6-hydroxydopamine treatment, Psychopharmacologia 27: 99–110.
Cooper, B. R., Breese, G. R., Grant, L., and Howard, J. L., 1973, Effects of 6-hydroxydopamine treatments on active avoidance responding: Evidence for involvement of brain dopamine, J. Pharmacol. Exp. Ther. 185: 358–370.
Cooper, B. R., Cott, J. M., and Breese, G. R., 1974a, Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments, Psychopharmacologia 377: 235–248.
Cooper, B. R., Howard, J. L., Grant, L. D., Smith, R. D., and Breese, G. R., 1974b, Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine, Pharmacol. Biochem. Behay. 2: 639–649.
Corrodi, H., and Hanson, L. C. F., 1966, Central effects of an inhibitor of tyrosine hydroxylation, Psychopharmacologia 10: 116–125.
Corrodi, H., Fuxe, K., Hamberger, B., and Ljungdahl, A., 1970, Studies on central and peripheral noradrenaline neurons using a new dopamine-ß-hydroxylase inhibitor, Eur. J. Pharmacol. 12: 145–155.
Coscina, D. V., Goodman, J., Godse, D., and Stancer, H. C., 1975, Effects of handling before central 6-hydroxydopamine treatment on subsequent emotionality and neurochemical changes in rats, Physiol. Psychol. 3: 225–228.
Costa, E., Lefevre, H., Meek, J., Revuelta, A., Spano, F., Strada, S., and Daly, J., 1972, Serotonin and catecholamine concentrations in brain of rats injected intracerebrally with 5,6-dihydroxytryptamine, Brain Res. 44: 304–308.
Costal!, B., and Naylor, R. J., 1974, The involvement of dopaminergic systems with the stereotyped behavior patterns induced by methylphenidate, J. Pharm. Pharmacol. 26: 3033.
Coyle, J. T., and Axelrod, J., 1972, Dopamine-ß-hydroxylase in the rat brain: Developmental characteristics, J. Neurochem. 19: 449–459.
Crabbe, J. C., and Alpern, H. P., 1973, Facilitation and disruption of the long-term store of memory with neural excitants, Pharmacol. Biochem. Behay. 1: 197–202.
Crabbe, J. C., and Alpern, H. P., 1975, d-Amphetamine: Disruptive effects on the long-term store of memory and proactive facilitatory effects on learning in inbred mice, Pharmacol. Biochem. Behay. 3: 647–652.
Creese, I., and Iversen, S. D., 1972, Amphetamine response in rat after dopamine neurone destruction, Nature (London), New Biol. 238: 247–248.
Creese, I., and Iversen, S. D., 1973, Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine, Brain Res. 55: 369–382.
Creese, I., and Iversen, S. D., 1974, The role of forebrain dopamine systems in amphetamine induced stereotyped behaviour in the rat, Psychopharmacologia 39: 345–357.
Creese, I., and Iversen, S. D., 1975a, The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res. 83: 419–436.
Creese, I., and Iversen, S. D., 1975b, Behavioral sequelae of dopaminergic degeneration: Postsynaptic supersensitivity?, in “Pre-and Post-Synaptic Receptors” (E. Usdin and W. E. Bunney, eds.), pp. 171–190, Marcel Dekker, New York.
Creese, I., Burt, D. R., and Snyder, S. H., 1976, The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states, Life Sci. 17: 1715–1720.
Creveling, C. R., Daly, J. W., Witkop, B., and Udenfriend, S., 1962, Substrates and inhibitors of dopamine-ß-oxidase, Biochim. Biophys. Acta 64: 125–134.
Crow, T. J., and Arbuthnott, G. W., 1972, Function of catecholamine-containing neurones in mammalian central nervous system, Nature (London), New Biol. 238: 245–246.
Crow, T. J., and Wendlandt, S., 1976, Impaired acquisition of a passive avoidance response after lesion induced in the locus coeruleus by 6-OH-dopamine, Nature (London) 259: 4244.
Curzon, G., and Marsden, C. A., 1975, The effect of L-tryptophan on changes in motor activity caused by parachlorophenylalanine, Br. J. Pharmacol. 54: 232.
Dahlstrom, A., and Fuxe, K., 1965, Evidence for the existence of monoamine containing neurons in the central nervous system. 1. Demonstration of the monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand. Suppl. 62, 232: 1–55.
Daly, J., Fuxe, K., and Jonsson, G., 1974, 5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydroxytryptamine neurons, Res. Commun. Chem. Pathol. Pharmacol. 7: 175–187.
Davidson, A. B., and Weidley, E., 1976, Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats, Life Sci. 18: 1279–1284.
Davies, J. A., and Redfern, P. H., 1974, The interaction of dopamine-antagonists and amantadine hydrochloride on the acquisition of the conditioned avoidance response in rats, Neuropharmacology 13: 941–948.
Davis, M., 1974, Sensitization of the rat startle response by noise, J. Comp. Physiol. Psychol. 87: 571–581.
Davis, M., and Sheard, M.H., 1974a, Habituation and sensitization of the rat startle response: Effects of raphe lesions, Physiol. Behay. 12: 425–431.
Davis, M., and Sheard, M. H., 1974b, Effects of lysergc acid diethylamide (LSD) on habituation and sensitization of the startle response in the rat, Pharmacol. Biochem. Behay. 2: 675–683.
Davis, M., and Sheard, M. H., 1974c, Biphasic dose—response effects of N,N-dimethyltryptamine on the rat startle reflex, Pharmacol. Biochem. Behay. 2: 827–829.
Davis, M., and Sheard, M. H., 1976, p-Chloroamphetamine (PCA): Acute and chronic effects on habituation and sensitization of the acoustic startle response in rats, Ear. J. Pharmacol. 35: 261–273.
Davis, M., Svensson, T. H., and Aghajanian, G. K., 1975, Effects of d-and I-amphetamine on habituation and sensitization of the acoustic startle response in rats, Psychopharmacology 43: 1–12.
Dawson, R. G., and McGaugh, J. L., 1973, Drug facilitation of learning and memory, in “The Physiological Basis of Memory” U. A. Deutsch, ed.), Academic, New York.
Deguchi, T., and Barchas, J., 1972, Regional distribution and developmental change of tryptophan hydroxylase activity in rat brain, J. Neurochem. 19: 927–929.
Dengler, H. J., Spiegel, H. E., and Titus, E. O., 1961, Uptake of tritium-labeled norepinephrine in brain and other tissues of cat in vitro, Science 133: 1072–1073.
Descarries, L., Beaudet, A., and Watkins, K. C., 1975, Serotonin nerve terminals in adult rat neocortex, Brain Res. 100: 563–588.
Dews, P. B., 1958, Studies on behavior. IV. Stimulant actions of methamphetamine, J. Pharmacol. Exp. Thar. 122: 137–147.
Dismukes, R. K., and Rake, A. V., 1972, Involvement of biogenic amines in memory formation, Psychopharmacologia 23: 17–25.
Doepfner, W. and Cerletti, A., 1958, Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat’s paw by serotonin, Int. Arch. Allergy (Basel) 12: 89–97.
Doty, B., and Doty, L., 1966, Facilitation effects of amphetamine on avoidance conditioning in relation to age and problem difficulty, Psychopharmacologia 9: 239–241.
Dowson, J. H., 1973, Quantitative histochemical studies of striatal dopamine depletion following m.-a-methyl-p-tyrosine administration, Neuropharmacology 12: 949–953.
Duch, D. S., Viveros, O. H., and Kirshner, N., 1968, Endogenous inhibitor(s) in adrenal medulla of dopamine-ß-hydroxylase, Biochem. Pharmacol. 17: 255–264.
Duncan, R. J. S., and Sourkes, T. L., 1974, Some enzymic aspects of the production of oxidized or reduced metabolites of catecholamines and 5-hydroxytryptamine by brain tissues, J. Neurochem. 22: 663–669.
Edwards, D. J., and Blau, K., 1972, The in vivo formation of p-chloro-ß-phenylethylamine in young rats injected with p-chlorophenylalanine, J. Neurochem. 19: 1829–1832.
Eichelman, B. S., Jr., Thoa, N. B., and Nq, K.Y., 1972, Facilitated aggression in the rat following 6-hydroxydopamine administration, Physiol. Behay. 8: 1–3.
Engel, J., 1971, Metatyrosine-induced reversal of the suppression of the conditioned avoidance response in reserpine-treated rats, Acta Pharmacol. Toxicol. 30: 1–10.
Engel, J., and Carlsson, A., 1976, Catecholamines and behavior, Curr. Develop. Psychopharmacol. 4: 3–31.
Engel, J., and Modigh, K., 1974, Trvptophan-induced suppression of conditioned avoidance behavior in rats, in “Advances in Biochemical Pharmacology” (E. Costa, G. L. Gessa, and M. Sandler, eds.), Vol. II, pp. 405–409, Raven, New York.
Erwin, V. G., and Deitrich, R. A., 1966, Brain aldehyde dehydrogenase. Localization, purification and properties, J. Biol. Chem. 241: 3533.
Essman, W. B., 1971, Role of biogenic amines in memory consolidation, in “Biology of Memory” (G. Adams, ed.), pp. 213–238, Plenum, New York.
Essman, W. B., 1973, Age dependent effects of 5-hydroxytryptamine upon memory consolidation and cerebral protein synthesis, Pharmacol. Biochem. Behay. 1: 7–14.
Essman, W. B., 1974, Brain 5-hydroxytryptamine and memory consolidation, in “Serotonin, New vistas—Biochemistry and Behavioral and Clinical Studies” (E. Costa, G. L., Gessa, and M. Sandler, eds.), pp. 265–274, Raven, New York.
Evangelista, A. M., and Izquierdo, I., 1971, The effect of pre-and post-trial amphetamine injections on avoidance responses of rats, Psychopharmacologia 20: 42–47.
Everett, G. M., and Borcherding, J. W., 1970, L-Dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice, Science 168: 849–850.
Evetts, K. D., and Iversen, L. L., 1970, Effects of protriptyline on the depletion of catecholamines induced by 6-hydroxydopamine in the brain of the rat, J. Pharm. Pharmacol. 22: 540–543.
Evetts, K. D., Uretsky, N. J., Iversen, L. L., and Iversen, S. D., 1970, Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity and amphetamine-induced hyperactivity in the rat, Nature (London) 225: 961–962.
Fahn, S., Rodman, J. S., and Cote, L. J., 1969, Association of tyrosine hydroxylase with synaptic vesicles in bovine caudate nucleus, J. Neurochem. 16: 1293–1300.
Farnebo, L. O., Fuxe, K., Goldstein, M., Hamberger, B., and Ungerstedt, U., 1971, Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson’s disease, Eur. J. Pharmacol. 16: 27–38.
Farrow, J. T., and Van Vunakis, H., 1973, Characteristics of n-lysergic acid diethylamide binding to subcellular fractions derived from rat brain, Biochem. Pharmacol. 22: 1103–1113.
Fernstrom, J. D., and Wurtman, R. J., 1971, Brain serotonin content: Physiological dependence on plasma tryptophan levels, Science 173: 149–152.
Fernstrom, J. D., and Wurtman, R. J., 1972, Brain serotonin content: Physiological regulation by plasma neutral amino acids, Science 178: 414–416.
Fernstrom, J. D., Faller, D. V., and Shabshelowitz, H., 1975, Acute reduction of brain serotonin and 5-HIAA following food consumption: Correlation with the ratio of serum tryptophan to the sum of competing neutral amino acids, J. Neural Transmission 36: 113–121.
Fibiger, H. C., and Campbell, B. A., 1971, The effect of para-chlorophenylalanine on spontaneous locomotor activity in the rat, Neuropharmacology 10: 25–32.
Fibiger, H. C., and Grewaal, D. S., 1974, Neurochemical evidence for denervation supersensitivity: The effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels, Life Sci. 15: 57–63.
Fibiger, H. C., Fibiger, H. P., and Zis, A. P., 1973, Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat, Br. J. Pharmacol. 47: 683–692.
Fibiger, H. C., Phillips, A. G., and Zis, A. P., 1974, Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection, Pharmacol. Biochem. Behay. 2: 87–96.
Fibiger, H. C., Zis, A. P., and Phillips, G., 1975, Haloperidol-induced disruption of conditioned avoidance responding: Attenuation by prior training or by anticholinergic drugs, Eur. J. Pharmacol. 30: 309–314.
Fog, R., 1969, Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs, Psychopharmacologia 14: 299–304.
Foldes, A., and Costa, E., 1975, Relationship of brain monoamine and locomotor activity in rats, Biochem. Pharmacol. 24: 1617–1621.
Foree, D. D., Moretz, F. H., and McMillan, D. E., 1973, Drugs and punished responding. II. d-Amphetamine-induced increases in punished responding, J. Exp. Anal. Behay. 20: 291–300.
Friedman, S., and Kaufman, S., 1965, 3,4-Dihydroxyphenylethylene-ß-hydroxylase: A copper protein, J. Biol. Chem. 240: 552–554.
Friedman, S., Kappelman, A. H., and Kaufman, S., 1972, Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain, J. Biol. Chem. 247: 4165–4173.
Frontali, M., Amorico, L., DeAcetis, L., and Bignami, G., 1976, A pharmacological analysis of processes underlying differential responding: A review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine, Behay. Biol. 18: 1–74.
Fuentes, J. A., and Neff, N. H., 1975, Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes, Neuropharmacology 14: 819–825.
Fuller, R. W., and Perry, K. W., 1974, Long-lasting depletion of brain serotonin by 4-chloramphetamine in guinea pigs, Brain Res. 82: 383–385.
Fuller, R. W., Baker, J. C., Perry, K. W., and Molloy, B. B., 1975, Comparison of 4-chloro-, 4-bromo-and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism, Neuropharmacology 14: 739–746.
Fuxe, K., and Jonsson, G., 1973, The histochemical fluorescence method for the demonstration of catecholamines: Theory, practice and application, J. Histochem. Cytochem. 21: 293–311.
Fuxe, K., Hökfelt, T., and Ungerstedt, U., 1968, Localization of indolealkylamines in CNS, in “Advances in Pharmacology” (S. Garattini and P. A. Shore, eds.), Vol. 6A pp. 235–251, Academic, New York.
Gal, E. M., Poczik, M., and Marshall, F. D., 1963, Hydroxylation of tryptophan to 5- hydroxytryptophan by brain tissue in vivo, Biochem. Biophys. Res. Commun. 12: 39–43.
Gal, E. M., Heater, R. D., and Millard, S. A., 1968, Studies on the metabolisms of 5hydroxytryptamine (serotonin). VI. Hydroxylation and amines in cold-stressed reserpinised rats, Proc. Soc. Exp. Biol. Med. (N.Y.) 128: 412–415.
Gal, E. M., Roggeveen, A. E., and Millard, S. A., 1970, nL[s-’4C]p-chlorophenylalanine as an inhibitor of tryptophan 5-hydroxylase, J. Neurochem. 17: 1221–1235.
Geller, I., and Blum, K., 1970, The effects of 5-HT on para-chlorophenylalanine (p-CPA) attenuation of “conflict” behavior, Eur. J. Pharmacol. 9: 319.
Geller, I., and Seifter, J., 1960, The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat, Psychopharmacologia 1: 482–492.
Gerson, S., and Baldessarini, R. J., 1975, Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine, Brain Res. 85: 140–145.
Gerson, S., Baldessarini, R. J., and Wheeler, S. C., 1974, Biochemical effects of dihydroxy- lated tryptamines on central indoleamine neurons, Neuropharmacology 13: 987–1004.
Geyer, M. A., 1976, Functional heterogeneity within neurotransmitter systems, Psychopharmacol. Commun. 1: 675–685.
Geyer, M. A., and Segal, D. S., 1973, Differential effects of reserpine and alpha-methyl-ptyrosine on norepinephrine and dopamine induced behavioral activity, Psychopharmacologia 29: 131–140.
Glowinski, J., and Iversen, L. L., 1966, Regional studies of catecholamines in the rat brain. I. The disposition of [3H1-norepinephrine, [3H]-dopamine and [3H1-dopa in various regions of the brain, J. Neurochem. 13: 655–669.
Goldstein, M., 1966, Inhibition of norepinephrine biosynthesis at the dopamine-ß-hydroxylation stage, Pharmacol. Rev. 18: 77–82.
Goldstein, M., Lauber, E., and McKereghan, M. R., 1965, Studies on the purification and characterization of 3,4-dihydroxyphenylethylamine-/3-hydroxylase, J. Biol. Chem. 240: 2066–2072.
Gorelick, D. A., Bozewicz, T. R., and Bridger, W. H., 1975, The role of catecholamines in animal learning and memory, in “Catecholamines and Behavior. 2” (A. J. Friedhoff ed.), pp. 1–30, Plenum, New York.
Gozzani, J. C., and Izquierdo, I., 1976, Possible peripheral adrenergic and central dopaminergic influences in memory consolidation, Psychopharmacology 49: 109–111.
Graeff, F. G., and Schoenfeld, R. I., 1970, Tryptaminergic mechanisms in punished and nonpunished behavior, J. Pharmacol. Exp. Ther. 173: 277–283.
Grahame-Smith, D. G., 1964, Tryptophan hydroxylation in brain, Biochem. Biophys. Res. Commun. 16: 586–592.
Grahame-Smith, D. G., 1967, The biosynthesis of 5-hydroxytryptamine in brain, Biochem. J. 105: 351–360.
Grahame-Smith, D. G., 197la, Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with monoamine oxidase inhibitor and L-tryptophan, J. Neurochem. 18: 1053–1066.
Grahame-Smith, D. G., 1971b, Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N, N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor, Br. J. Pharmacol. 43: 856–864.
Grahame-Smith, D. G., 1973, Does the total turnover of brain 5-HT reflect the functional activity of 5-HT in brain?, in “Serotonin and Behavior” (J. Barchas, and E. Usdin, eds.), pp. 5–7, Academic, New York.
Green, H., Greenberg, S. M., Erickson, R. W., Sawyer, J. L., and Ellison, T., 1962, Effect of dietary phenylalanine and tryptophan upon rat brain amine levels, J. Pharmacol. Exp. Ther. 136: 174–178.
Grelak, R. P., Clark, R., Stump, J. M., and Vernier, V. G., 1970, Amantadine—dopamine interaction. Possible mode of action in Parkinsonism, Science 169: 203–204.
Griffiths, D., and Wahlsten, D., 1974, Interacting effects of handling and d-amphetamine on avoidance learning, Pharm. Biochem. Behay. 2: 439–441.
Grossman, S. P., 1968, Behavioral and electroencephalographic effects of microinjections of neurohumors into the midbrain reticular formation, Physiol. Behay. 3: 777–786.
Grossman, S. P., and Sclafani, A., 1971, Sympathomimetic amines, in “Pharmacological and Biophysical Agents and Behavior” (E. Furchtgott, ed.), Academic, New York.
Groves, P. M., and Thompson, R., 1970, Habituation: A dual process theory, Psychol. Rev. 77: 419–450.
Guroff, G., Kondo, K., and Daly, J., 1966, The production of metachlorotyrosine from parachlorophenylalanine by phenylalanine hydroxylase, Biochem. Biophys. Res. Commun. 25: 622–628.
Häggendal, J., and Dalström, A., 1972, The recovery of the capacity for uptake—retention of [3H]-noradrenaline in rat adrenergic nerves after reserpine, J. Pharm. Pharmacol. 24: 565–574.
Halaris, A. E., and Freedman, D. X., 1975, Psychotropic drugs and dopamine uptake inhibition, in “Biology of the Major Psychoses” (D. X. Freedman, ed.), Vol. 54, Raven, New York.
Halaris, A. E., Belendiuk, K. T., and Freedman, D. X., 1975, Antidepressant drugs affect dopamine uptake, Biochem. Pharmacol. 24: 1896–1898.
Hall, M. E., 1976, The effects of norepinephrine biosynthesis inhibition on the consolidation of two discriminated escape responses, Behay. Biol. 16: 145–153.
Hall, M. E., and Mayer, M. A., 1975, Effects of alpha methyl-para-tyrosine on the recall of a passive avoidance response, Pharmacol. Biochem. Behay. 3: 579–582.
Hanson, L.C.F., 1967a, Evidence that the central action of (+) amphetamine is mediated via catecholamines, Psvchopharmacologia 10: 289–297.
Hanson, L.C.F., 1967b, Biochemical and behavioral effects of tyrosine—hydroxylase inhibition, Psychopharmacologia 11: 8–17.
Hanson, L.C.F., 1965, The disruption of conditioned avoidance response following selective depletion of brain catecholamines, Psychopharmacologia 8: 100–110.
Hartmann, R. J., and Geller, I., 1971, p-Chlorophenylalanine effects on a conditioned emotional response in rats, Life Sci.10(1):927–933.
Harvey, J. A., McMaster, S. E., and Yunger, L. M., 1975, p-Chloroamphetamine: Selective neurotoxic action in brain, Science 187: 841–843.
Hedreen, J. C., and Chalmers, J. P., 1972, Neuronal degeneration in rat brain induced by 6-hydroxydopamine; A histological and biochemical study, Brain Res. 47: 1–36.
Heikkila, R., and Cohen, G., 1973, 6-Hydroxydopamine: Evidence for superoxide radical as an oxidative intermediate, Science 181: 456–458.
Heise, G. A., and Boff, E., 1971, Stimulant action of d-amphetamine in relation to test compartment dimensions and behavioral measure, Neuropharmacology 10: 259–266.
Heise, G. A., and Lilie, N. L., 1970, Effects of scopolamine atropine and d-amphetamine on internal and external control of responding on non-reinforced trials, Psychopharmacologia 18: 38–39.
Heise, G. A., Laughlin, N., and Keller, C., 1970, A behavioral and pharmacological analysis of reinforcement withdrawal, Psychopharmacologia 16: 345–368.
Herman, Z. S., 1970, The effects of noradrenaline on rats’ behaviour, Psychopharmacologia 16: 369.
Hidaka, H., 1973, Picolinic acid derivatives as inhibitors of dopamine-ß-hydroxylase in vivo; their effects on blood pressure and stress ulcer, in “Frontiers in Catecholamine Research” (E. Usdin and S. Snyder, eds.), pp. 87–90, Pergamon, Oxford.
Hillarp, N. A., Fuxe, K., and Dahlstrom, A., 1966, Demonstration and mapping of central neurons containing dopamine, noradrenaline and 5-hydroxytryptamine and their reactions to psychopharmaca, Pharmacol. Rev. 18: 727–741.
Hingtgen, J. N., Smith, J. E., Shea, P. A., Aprison, M. H., and Gaff, T. M., 1976, Cholinergic changes during conditioned suppression in rats, Science 193: 193–195.
Hökfelt, T., 1973, Neuronal catecholamine storage vesicles, in “Frontiers in Catecholamine Research” (E. Usdin and S. H. Snyder, eds.), pp. 439–446, Pergamon, New York.
Hökfelt, T., Fuxe, K., Goldstein, M., and Johansson, O., 1974, lmmunohistochemical evidence for the existence of adrenaline neurons in the rat brain, Brain Res. 66: 235–251.
Hole, K., and Lorens, S. A., 1975, Response to electric shock in rats: Effects of selective midbrain raphé lesions, Pharmacol. Biochem. Behay. 3 (1): 95–102.
Hole, K., Fuxe, K., and Jonsson, G., 1976, Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways, Brain Res. 107: 385–399.
Hollister, A. S., Breese, G. R., and Cooper, B. R., 1974, Comparison of tyrosine hydroxylase and dopamine-ß-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity, Psychopharmacologia 36: 1–16.
Holzbauer, M., and Sharman, D. F., 1972, The distribution of catecholamines in vertebrates, in “Catecholamines” (H. Blashko and E. Muscholl, eds.), pp. 110–185, Springer, Berlin.
Hornykiewicz, O., 1966, Dopamine (3-hydroxytyramine) and brain function, Pharmacol. Rev. 18: 925–964.
Howard, J. L., Grant, L. D., and Breese, G. R., 1974, Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze, J. Comp. Physiol. Psychol. 86: 995–1007.
Ichiyama, A., Nakamura, S., Nishizuka, Y., and Hayaishi, O., 1968, Tryptophan 5-hydroxylase in mammalian brain, in “Advances in Pharmacology” (S. Garattini and P. A. Shore, eds.), Vol. 6a, pp. 5–17, Academic, New York.
Iversen, S. D., and Iversen, L. L., 1975, “Behavioral Pharmacology” Oxford University Press.
Izquierdo, I., 1974, Effect on pseudoconditioning of drugs with known central nervous activity, Psychopharmacologie 38: 259–266.
lzquierdo, I., 1975, Relations between orienting pseudoconditioned and conditioned responses in the shuttle-box—A pharmacological analysis by means of LSD and dibenamine, Behay. Biol. 15: 193–206.
Izquierdo, I., 1976, A pharmacological separation of buzzer-shock pairing and of the shuttle-shock contingency as factors in the elicitation of shuttle responses to a buzzer in rats, Behay. Biol. 18: 75–88.
Izquierdo, I., and Cavalheiro, E. A., 1976, Three main factors in rat shuttle behavior: Their pharmacology and sequential entry in operation during a two-way avoidance session, Psychopharmacolorl 49: 145–158.
Izquierdo, J. A., 1974, Animal behavior: Influence of drugs affecting monoaminergic and cholinergie neuro-transmission, Acta Physiol. Lat. Am. 24: 644–655.
Izquierdo, J. A., Jofré, I. J., and Acevedo, C., 1972, Effect of disulfiram and ascorbic acid on catecholamine content in rat brain, J. Pharm. Pharmacol. 24: 330–332.
Jacobowitz, D., and Kostrzewa, R., 1971, Selective action of 6-hydroxydopa on noradrenergic terminals: Mapping of preterminal axons of the brain, Life Sci. 10 (1): 1329–1342.
Jacobs, B. L., 1974, Evidence for the functional interaction of two central neurotransmitters, Psychopharmacologia 39: 81–86.
Jacobs, B. L., and Cohen, A., 1976, Differential behavioral effects of lesions of the median or dorsal raphé nuclei in rats: Open field and pain-elicited agression, J. Comp. Physiol. Psychol. 90: 102–108.
Jacobs, B. L., Eubanks, E. E., and Wise, W. D., 1974a, Effect of indole-alkylamine manipulations on locomotor activity in rats, Neuropharmacology 13: 575–583.
Jacobs, B. L., Wise, W. D., and Taylor, K. M., 1974b, Differential behavioral and neurochemical effects following lesions of the dorsal or median raphé nuclei in rats, Brain Res. 79: 353–361.
Jacobs, B. L., Wise, W. D., and Taylor, K. M., 1975a, Is there a catecholamine-serotonin interaction in the control of locomotor activity?, Neuropharmacology 14: 501–506.
Jacobs, B. L., Trimback, C., Eubanks, E. E., and Trulson, M., 1975b, Hippocampal mediation of raphé lesion-and PCPA-induced hyperactivity in the rat, Brain Res. 94: 253–261
Jacobs, B. L., Mosko, S. S., and Trulson, M. E., 1976, in “Neurobiology of Sleep and Memory” (R. R. Drucker and J. L. McGaugh, eds.), Academic, New York.
Jacoby, J. H., Shabshelowitz, H., Fernstrom, J. D., and Wurtman, R. J., 1975, The mechanisris by which methiothepin, a putative serotonin receptor antagonist, increases brain 5-hydroxyindole levels, J. Pharmacol. Exp. Ther. 195: 257–264.
Jalfre, M., Ruch-Monachon, M. A., and Haefely, W., 1974, Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain, in “Advances in Biochemical Psychopharmacology” (E. Costa, G. L. Gessa and M. Sandler, eds.), Vol. 10, pp. 121–134, Raven, New York.
James, D.T.D., 1975, Postrial d-amphetamine sulfate and one-trial learning in mice, J. Comp. Physiol. Psychol. 89: 626–635.
Jéquier, E., Lovenberg, W., and Sjoerdsma, A., 1967, Tryptophan hydroxylase inhibition: The mechanism by which p-chlorophenylalanine depletes rat brain serotonin, Mol. Pharmacol. 3: 274–278.
Johnson, G. A., Kim. E. G., and Boukma, S. J., 1972, 5-Hydroxyindole levels in rat brain after inhibition of dopamine-f3-hydroxylase, J. Pharmacol. Exp. Ther. 180: 539–546.
Johnston, J. P., 1968, Some observations upon a new inhibitor of monoamine oxidase in brain tissue, Biochem. Pharmacol. 17: 1285–1297.
Jonsson, G., and Sachs, C., 1971, Uptake and accumulation of 3H-6-hydroxydopamine in adrenergic nerves, Eur. J. Pharmacol. 16: 55–62.
Jonsson, G., Pycock, C. L., Fuxe, K., and Sachs, C., 1974, Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine, J. Neurochem. 22: 419–426.
Karoum, F., Gillin, J. C., Wyatt, R. J., and Costa, E., 1975, Mass-fragmentography of nanogram quantities of biogenic amine metabolites in human cerebrospinal fluid and whole rat brain, Biomed. Mass Spectrum. 2: 183–189.
Katzman, R., Björklund, A., Owman, C., Stenevi, U., and West, K. A., 1971, Evidence for regenerative axon sprouting of central catecholamine neurons in the mesencephalon following electrolytic lesions, Brain Res. 25: 579–596.
Kaufman, S., 1963, The structure of the phenylalanine-hydroxylation cofactor, Proc. Natl. Acad. Sci. U.S.A. 50: 1085–1093.
Kehr, W., Carlsson, A., and Lindqvist, M., 1972, A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain, Arch. Pharmacol. 274: 273–280.
Kelleher, R. T., and Morse, W. H., 1968, Determinants of the specificity of behavioral effects of drugs, Ergeb. Physiol. Biol. Chem. Exp. Pathol. 60: 1–56.
Keller, H. H., Bartholini, G., and Pletscher, A., 1974, Enhancement of noradrenaline turnover in rat brain by l-dopa, J. Pharm. Pharmacol. 26: 649–651.
Kelly, P. H., and Iversen, L. L., 1975, LSD as a agonist at mesolimbic dopamine receptors, Psychopharmacologia 45: 221–224.
Kety, S. S., 1970, The biogenic amines in the central nervous system: Their possible roles in arousal, emotion and learning, in “The Neurosciences, Second Study Program” (G.C., Quenton, T. Melnechuk, and G. Adelman, eds.), The Rockefeller University Press, New York.
Kirshner, N., and Goodall, M. C., 1957, The formation of adrenaline from noradrenaline, Biochem. Biophys, Acta 24: 658–659.
Knapp. S., and Mandell, A. J., 1972, Parachlorophenylalanine—Its three phase sequence of interactions with the two forms of brain tryptophan hydroxylase, Life Sci. 11 (I): 761–771.
Koe, B. K., and Corkey, R. F., 1976, Inhibition of rat brain tryptophan hydroxylation with pchloroamphetamine, Biochem. Pharmacol. 25: 31–35.
Koe, B. K., and Weissman, A., 1966, p-Chlorophenylalanine: A specific depletor of brain serotonin, J. Pharmacol. Exp. Ther. 154: 499–516.
Koe, B. K., and Weissman, A., 1968, The pharmacology of Para-chlorophenylalanine, a selective depletor of serotonin stores, Adv. Pharmacol. 6B: 29–47.
Kokkinidis, L., and Anisman, H., 1976a, Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task, Psychopharmacology 48: 261–270.
Kokkinidis, L., and Anisman, H., 1976b, Dissociation of the effects of scopolamine and damphetamine on spontaneous alternation: Genuine perseveration or dishabituation, Pharm. Biochem. Behay. 5: 293–297.
Kokkinidis, L., and Anisman, H., 1977, Perseveration and rotational behavior elicited by d-amphetamine in a Y-maze exploratory task: Differential effects of intraperitoneal and unilateral intraventricular administration, Psychopharmacology 52: 123–128.
Kopin, I. J., Breese, G. R., Krauss, K. R., and Weise, V. K., 1968, Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation, J. Pharmacol. Exp. Ther. 161: 271–278.
Korf, J., and Van Praag, H. M., 1972, Action of p-chloroamphetamine on cerebral serotonin metabolism: An hypothesis, Neuropharmacology 11: 141–144.
Kostowski, W., Giacolone, E., Garattini, S., and Valzelli, L., 1968, Studies on behavioural and biochemical changes in rats after lesion of midbrain raphé, Eur. J. Pharmacol. 4: 371–376.
Kostrzewa, R. M., 1975, Effects of neonatal 6-hydroxydopa treatment on monoamine content of rat brain and peripheral tissues, Res. Commun. Chem. Path. Pharmacol. 11: 567–579.
Kostrzewa, R. M., and Garey, R. E., 1976, Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain, J. Pharmacol. Exp. Ther. 197: 105–118.
Krieckhaus, E. E., Miller, N. E., and Zimmerman, P., 1965, Reduction of freezing behavior and improvement of shock avoidance by d-amphetamine, J. Comp. Physiol. Psychol. 60: 36–40.
Kuczenski, R. T., and Mandell, A. J., 1972, Regulatory properties of soluble and particulate rat brain tyrosine hydroxylase, J. Biol. Chem. 247: 3114–3122.
Kuczenski, R. T., and Segal, D. S., 1975, Differential effects of o-and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis, Ear. J. Pharmacol. 30: 244–251.
Kuhar, M. J., Aghajanian, G. K., and Roth, R. H., 1972, Trypotophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphé lesions: Correlations with serotonin levels and histochemical fluorescence, Brain Res. 44: 165–176.
Kulkarni, A. S., 1968, Facilitation of instrumental avoidance learning by amphetamine: An analysis, Psychopharmacologia 13: 418–425.
Kulkarni, A. S., 1972, Selective increase in avoidance responding by methamphetamine in naive rats, Psychopharmacologia 24: 449–455.
Kumar, R., 1971, Extinction of Fear. I: Effects of amylobarbitone and dexamphetamine given separately and in combination on fear and exploratory behaviour in rats, Psychopharmacologia 19: 163–187.
Laduron, P., and Belpaire, F., 1968, Transport of noradrenaline and dopamine-ß-hydroxylase in sympathetic nerves, Life Sci. 7 (1): 1–7.
Lagercrantz, H., and Stjärne, L., 1974, Evidence that most noradrenaline in sympathetic large dense core nerve vesicles is stored without ATP, Nature (London) 249: 843–845.
Lassen, J. B., 1973, The effect of amantadine and (+)amphetamine on motility in rats after inhibition of monoamine synthesis and storage, Psychopharmacology 29: 55–64.
Laties, V. G., 1972, The modification of drug effects on behavior by external discriminative stimuli, J. Pharmacol. Exp. Ther. 183: 1–13.
Laties, V. G., and Weiss, B., 1966, Influence of drugs on behavior controlled by internal and external stimuli, J. Pharmacol. Exp. Ther. 152: 388–396.
Latz, A., Bain, G. T., Kornetsky, C., 1969, Attenuated effect of chlorpromazine on conditioned avoidance as a function of rapid acquisition, Psychopharmacologia 14: 23–32
Laverty, R., and Taylor, K. M., 1970, Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behavior and brain catecholamine metabolism, Br. J. Pharmacol. 40: 836–846.
Leith, N. J., and Barrett, R. J., 1975, Effects of hippocampal microinjections of d-amphetamine and scopolamine on active avoidance behaviour in rats, J. Comp. Physiol. Psychol. 88: 285–299.
LeMoal, M., Galey, D., and Cardo, B., 1975, Behavioral effects of local injection of 6hydroxydopamine in the medial ventral tegmentum in the rat. Possible role of the mesolimbic dopaminergic system, Brain Res. 88: 190–194.
Lenard, L. G., and Beer, B., 1975a, 6-Hydroxydopamine and avoidance: Possible role of response suppression, Pharmacol. Biochem. Behay. 3: 873–878.
Lenard, L. G., and Beer, B., 1975b, Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors, Pharmacol. Biochem. Behay. 3: 887–893.
Lenard, L. G., and Beer, B., 1975c, Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6hydroxydopamine, Pharmacol. Biochem. Behay. 3: 895–899.
Levison, P. K., and Freedman, D. X., 1967, Recovery of discriminated lever press avoidance performance from the effects of reserpine, chlorpromazine and tetrabenazine, Arch. Int. Pharmacodvn. Ther. 170: 31–38.
Levitt, M., Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, Elucidation of the ratelimiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J. Pharrnacol. Exp. Ther. 148: 1–8.
Lindvall, O., and Björklund, A., 1974, The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method, Acta Physiol. Scand. Suppl. 412: 1–48.
Lindvall, O., Björklund, A., Nobin, A., and Stenevi, U., 1974a, The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method, J. Comp. Neurol. 154: 317–348.
Lindvall, O., Björklund, A., Moore, R. Y., and Stenevi, U., 1974b, Mesencephalic dopamine neurons projecting to neocortex, Brain Res. 81: 325–331.
Lord, B. J., King, M. G., and Pfister, H. P., 1976, Chemical sympathectomy and two-way escape and avoidance learning in the rat, J. Comp. Physiol. Psychol. 90: 303–316.
Lorens, S. A., 1973, Raphé lesions in cats: Forebrain serotonin avoidance behavior, Pharmacol. Biochem. Behay. 1: 487–490.
Lorens, S. A., and Yunger, L. M., 1974, Morphine analgesia, two-way avoidance, and consummatory behavior following lesions in the midbrain raphé muclei of the rat, Pharmacol. Biochem. Behar. 2: 215–221.
Lorens, S. A., Gulberg, H. C., Hole, K. Kolater, C., and Srebro, B., 1976, Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphé lesions in rats, Brain Res. 108: 97–114.
Lorez, H. P., Pieri, L., and Richards, J. G., 1975, Diappearance of supraependymal 5-HT axons in the rat forebrain after electrolytic and 5,6-DHT-induced lesions of the medial forebrain bundle, Brain Res. 100: 1–12.
Lovenberg, W., and Victor, S. J., 1974, Regulation of tryptophan and tyrosine hydroxylase, Life Sci. 14: 2337–2353.
Lovenberg, W., Weissbach, H., and Udenfriend, S., 1962, Aromatic L-amino acid decarboxylase, J. Biol. Chem. 237: 89–93.
Lyon, M., 1971, The effect of no-shock or continuous shock upon avoidance behavior in rats under d-amphetamine, Act. Nerv. Super. 13: 78–81.
Lyon, M., and Randrup, A., 1972, The dose—response effect of amphetamine upon avoidance behaviour in the rat seen as a function of increasing stereotypy, Psychopharmacologia 23: 334–347.
Lytle, L. D., Jacoby, J. H., Nelson, M. F., and Baumgarten, H. G., 1975, Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines, Life Sci. 15: 1203–1217.
Mabry, P. D., and Campbell, B. A., 1973, Serotonergic inhibition of catecholamine-induced behavioural arousal, Brain Res. 49: 381–391.
Maj, J., and Pawlowski, L., 1975, 1 he effect of r,-5-hydroxytryptophan (5-HIP) on locomotor activity in mice, Pol. J. Pharmacol. Pharm. Suppl. 27: 145–149.
Margules, D. L., 1971, Localization of anti-punishment actions of norepinephrine and atropine in amygdala and endopeduncular nucleus of rats, Brain Res. 35: 177–184.
Marsden, C. A., and Curzon, G., 1976, Studies on the behavioral effects of tryptophan and p-chlorophenylalanine, Neuropharmacology 15: 165–171.
Mason, S. T., and Iversen, S. D., 1975, Learning in the absence of forebrain noradrenaline, Nature (London) 258: 422–424.
Massari, V. J., and Sanders-Bush, E., 1975, Synaptosomal uptake and levels of serotonin in rat brain areas after p-chloroamphetamine or B-9 lesions, Eur. J. Pharmacol. 33: 419–422.
McBride, W. J., Hyde, T. P., Smith, J. E., Lane, J. D., and Aprison, M. H., 1976, Effects of tryptophan on serotonin in nerve endings, J. Neurochem. 26: 175–178.
McGaugh, J. L., 1966, Time-dependent processes in memory storage, Science 153: 1351–1358.
McGaugh, J. L., and Petrinovich, L. F., 1965, Effects of drugs on learning and memory, Inter. Rev. Neurobiol. 8: 139–191.
McGeer, E. G., and McGeer, P. L., 1967, In vitro screen of inhibitors of rat brain tyrosine hydroxylase, Can. J. Biochem. 45: 115–131.
McGeer, E. G., and Peters, D. A. V., 1969, In vitro screen of inhibitors of rat brain serotonin synthesis, Can. J. Biochem. 47: 501–506.
McGeer, E. G., Gibson, S., and McGeer, P. L., 1967a, Some characteristics of brain tyrosine hydroxylase, Can. J. Biochem. 45: 1557–1563.
McGeer, E. G., Gibson, S., Wada, J. A., and McGeer, P. L., 1967b, Distribution of tyrosine hydroxylase activity in adult and developing brain, Can. J. Biochem. 45: 1943–1952.
McGeer, E. G., McGeer, P. L., and Peters, D. A., 1967c, Inhibition of brain tyrosine hydroxylase by 5-halotryptophan, Life Sci. 6: 2221–2232.
McGeer, E. G., McGeer, P. L., and Wada, J. A., 1971, Distribution of tyrosine hydroxylase in human and animal brain, J. Neurochem. 18: 1647–1658.
McGeer, P. L., Bagchi, S. P., and McGeer, E. G., 1965, Subcellular localization of tyrosine hvdroxylase in beef caudate nucleus, Life Sci. 4: 1859–1867.
McKearney, J. W., 1972, Schedule-dependent effects: Effects of drugs, and maintenance of responding with response-produced electric shocks, in “Schedule Effects: Drugs, Drinking and Aggression” (R. M. Gilbert and J. D. Keehn, eds.), Toronto Press, Canada
McKearney, J. W., 1973, Methamphetamine effects on responding under a multiple schedule of shock presentation, Pharmacol. Biochem. Behay. 1: 547–550.
McKearney, J. W., 1974, Effects of d-amphetamine, morphine and chlorpromazine on responding under fixed interval schedules of food presentation or electric shock presentation, J. Pharmacol. Exp. Ther. 190: 141–153.
McKearney, J. W., and Barrett, J. E., 1975, Punished behavior: Increases in responding after d-amphetamine, Psychopharmacologia 41: 23–26.
McLean, J. H., Kostrzewa, R. M., and May, J. G., 1976, Behavioral and biochemical effects of neonatal treatment of rats with 6-hydroxydopa, Pharmacol. Biochem. Behay. 4: 601–607.
McMillan, D. E., 1968, The effects of sympathomimetic amines on schedule-controlled behavior in the pigeon, J. Pharmacol. Exp. Ther. 160: 315–325.
McMillan, D. E., 1973, Drugs and punished responding. I: Rate-dependent effects under multiple schedules, J. Exp. Anal. Behay. 19: 133–145.
Meek, J. L., and Bertilsson, L., 1975, Comparison of the effects of lesion in the “B-9” cell body group and p-chloroamphetamine on tryptophan hydroxylase and 5-hydroxytryptamine in rat brain nuclei, Brain Res. 100: 140–144.
Messing, R. B., Phebus, L., Fisher, L. A., and Lytle L. D., 1976, Effects of p-chloroamphetam- ine on locomotor activity and brain 5-hydroxyindoles, Neuropharmacology 15: 157–164.
Michaelson, I. A., Whittaker, V. P., Laverty, R., and Sharman, D. F., 1963, Localization of acetylcholine, 5-hydroxytryptamine and noradrenaline within subcellular particles derived from guinea-pig subcortical tissue, Biochem. Pharmacol. 12: 1450–1453.
Miczek, K. A., 1973a, Effects of scopolamine, amphetamine and chlordiazepoxide on punishment, Psychopharmacologia 28: 373–389.
Miczek, K. A., I973b, Effects of scopolamine, amphetamine and benzodiazepines on conditioned suppression, Pharmacol. Biochem. Behay. 1: 401–411.
Millard, S. A., Costa, E., and Gal, E. M., 1972, On the control of brain serotonin turnover rate by end product inhibition, Brain Res. 40: 545–551.
Miller, K. W., Sanders-Bush, E., and Dingell, J. V., 1971, p-Chloroamphetamine-species differences in the rate of diappearance and lowering of cerebral serotonin, Biochem. Pharmacol. 20: 500–503.
Milner, V. S., 1974, Effects of d-amphetamine on acquisition of lever press Sidman avoidance in rats, Physiol. Psychol. 2: 392–396.
Modigh, K., 1972, Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice, Psychopharmacologia 23: 48–54.
Modigh, K., 1974, Studies on DL-5-hydroxytryptophan induced hyperactivity in mice, in “Serotonin: New Vistas. Histochemistry and Pharmacology” (E. Costa, G. L. Gessa, and M. Sandler, eds.), Raven, New York.
Mogilnicka, E., and Przewlocka, B., 1975, The influence of dopamine-beta-hydroxylase inhibitors on avoidance reaction in rat, Pol. J. Pharmacol. Pharm. 27: 513–519.
Mogilnicka, E., and Braestrup, C., 1976, Noradrenergic influence on the stereotyped behavior induced by amphetamine, phenethylamine and apomorphine, J. Pharm. Pharmacol. 28: 253–255.
Molander, L., and Randrup, A., 1974, Investigation of the mechanisms by which 1-DOPA induces gnawing in mice, Acta Pharmacol. Toxicol. 34: 312–324.
Molinoff, P. B., and Axelrod, J., 1971, Biochemistry of catecholamines, Ann. Rev. Biochem. 40: 465–500.
Monti, J. M., and Ruiz, M., 1973, Potentiation of the haloperidol induced blockade of a conditioned avoidance response by a-methyl-tyrosine, Eur. J. Pharmacol. 24: 25–28.
Monti, J. M., and Ruiz, M., 1975, Increased disrupting effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatment, Pharmacol. Biochem. Behay. 3: 943–945.
Moore, K. E., 1966, Toxicological studies with a-methyl tyrosine (a-MT), Fed. Proc. Fed. Am. Soc. Exp. Biol. 25: 688.
Moore, K. E., and Dominic, J. A., 1971, 1 yrosine hydroxylase inhibitors, Fed. Proc. Fed. Am. Soc. Exp. Biol. 30: 859–870.
Moore, K. E., and Rech, R. H., 1967a, Reversal of a-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine, J. Pharm. Pharmacol. 19: 405–407.
Moore, K. E., and Rech, R. H., 1967b, Antagonism by monoamine oxidase inhibitors of amethyltyrosine induced catecholamine depletion and behavioral depression, J. Pharmacol. Exp. Ther. 156: 70–75.
Mueller, R. A., Thoenen, H., and Axelrod, J., 1969a, Inhibition of trans-synaptically increased tyrosine hydroxylase activity by cycloheximide and actinomycin D, Mol. Pharmacol. 5: 463–469.
Mueller, R. A., Thoenen, H., and Axelrod, J., 1969b, Increase in tyrosine hydroxylase activity after reserpine administration, J. Pharmacol. Exp. Ther. 169: 74–79.
Musacchio, J., Goldstein, M., Anagnoste, B., Poch, G., and Kopin, I. J., 1966, Inhibition of dopamine-/3-hydroxylase by disulfiram in vivo, J. Pharmacol. Exp. Ther. 152: 56–61.
Nagatsu, T., Levitt, M., and Udenfriend, S., 1964, Tyrosine hydrosylase. The initial step in norepinephrine biosynthesis, J. Biol. Chem. 239: 2910–2917.
Nagatsu, T., Kuzuya, H., and Hidaka, H., 1967, Inhibition of dopamine-ß-hydroxylase by sulfhydryl compounds and the nature of the natural inhibitors, Biochim. Biophys. Acta 139: 319–327.
Nagatsu, T., Sudo, Y., and Nagatsu, I., 1971, Tyrosine hydroxylase in bovine caudate nucleus, J. Neurochem. 18: 2179–2189.
Nagatsu, T., Kako, T., Kuzuya, H., Umezawa, H., and Takeuchi, T., 1973, New inhibitors of microbial origin for dopamine-ß-hydroxylase, in “Frontiers in Catecholamine Research” (E. Usdin and S. Snyder, eds.), pp. 83–86, Pergamon, Oxford.
Nakamura, K., and Thoenen, H., 1972, Increased irritability: A permanent behavior change induced in the rat by intraventricular administration of 6-hydroxydopamine, Psychopharmacologia 24: 359–372.
Nakamura, K., and Nakamura, K., 1976, Behavioral and neurochemical changes following administration of 6-hydroxydopamine into the ventral tegmental area of the midbrain, Japan. J. Pharmacol. 26: 269–273.
Naylor, R. J., and Olley, J. E., 1972, Modification of the behavioural changes induced by haloperidol in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus, Neuropharmacology 11: 81–89.
Neill, D. B., Boggan, W. O., and Grossman, S. P., 1974, Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine, Pharmacol. Biochem. Behay. 2: 97–103.
Niemegeers, C.J.E., Verbruggen, F. J., and Janssen, P.A.J., 1969, The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure, Psychopharmacologia 16: 161–174.
Niemegeers, C.J.E., Verbruggen, F. J., and Janssen, P. A., 1970, The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure, Psychopharmacologia 17: 151–159.
Niemegeers, C.J.E., Verbruggen, F. J., Wauquier, A., and Janssen, P.A.J., 1972, The influence of haloperidol and amphetamine on two different noise-escape situations in rats, Psychopharmacologia 25: 22–31.
Nikodidevic, B., Creveling, C. R., and Udenfriend, S., 1963, Inhibition of dopamine-[3hydroxylase in vivo by benzyloxyamine and benzylhydrazine analogs, J. Pharmacol. Exp. Ther. 140: 224–228.
Nygren, L. G., Olson, L., and Seiger, A., 1971, Regeneration of monoamine-containing axons in the developing and adult spinal cord of the rat following intraspinal 6-OHdopamine injections or transections, Histochemie 28: 1–15.
Nygren, L. G., Fuxe, K., Jonsson, G., and Olson, L., 1974, Functional regeneration of 5hydroxytryptamine nerve terminals in the rat spinal cord following 5,6-dihydroxytryptamine induced degeneration, Brain Res. 78: 377–394.
Olton, D. S., 1973, Shock-motivated avoidance and the analysis of behavior, Psyclwl. Bull. 79: 243–251.
Osborne, R. H., and Kerkut, G. A., 1972, Inhibition of noradrenaline biosynthesis and its effects on learning in rats, Comp. Gen. Pharmacol. 3: 359–362.
Otten, U., Paravicini, U., Oesch, F., and Thoenen, H., 1973, Time requirement for the single steps of trans-synaptic induction of tyrosine hydroxylase in the peripheral sympathetic nervous system, Naumn-Schrniedelherg’s Arch. Pharmacol. 280: 117–127.
Pappas, B. A., 1974, Immunological and chemical sympathectomy in the neonatal rodent: Effects on emotional behavior, in “Limbic and Autonomic Nervous Systems Research” (L. V. Dilara, ed.), Plenum, New York.
Pappas, B. A., and Sobrian, S. K., 1972, Neonatal sympathectomy by 6-hydroxydopamine in the rat: No effects on behavior but changes in endogenous brain norepinephrine, Life Sci. 11: 653–659.
Pappas, B. A., Peters, D.A.V., Saari, M., Sobrian, S. K., and Minch, E., 1974, Neonatal 6hydroxydopamine sympathectomy in normotensive and spontaneously hypertensive rat, Pharmacol. Biochem. Behay. 2: 381–386.
Pappas, B. A., Peters, D.A.V., Sobrian, S. K., Blouin, A., and Drew, B., 1975, Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat, Pharm. Biochem. Behay. 3: 681–685.
Pappas, B. A., Saari, M., and Peters, D.A.V., 1976, Regional brain catecholamine levels after intraventricular 6-hydroxydopamine in the neonatal rat, Res. Commun. Chem. Pathol. Pharmacol. 14: 751–754.
Pérez-Cruet, J., Chase, T. N., and Murphy, D. L., 1974, Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans, Nature (London) 248: 693–695.
Persip, G. L., and Hamilton, L. W., 1973, Behavioral effects of serotonin or a blocking agent applied to the septum of the rat. Pharmarol. Biochem. Behay. 1: 139–147.
Peters, D.A.V., 1971, Inhibition of serotonin biosynthesis of 6-halotryptophans in vivo, Biochem. Pharmacol. 20: 1413–1420.
Peters, D.A.V., McGeer, P. L., and McGeer, E. G., 1968, The distribution of tryptophan hydroxylase in cat brain, J. Neurochem. 15: 1431–1435.
Peters, D.A.V., Filczewski, M., and Mazurkiewicz-Kwilecki, M., 1972, Effect of parachlorophenylalanine on catecholamine synthesis in rat brain, heart and adrenals, Biochem. Pharmacol. 21: 2282–2284.
Peters, D.A.V., Mazurkiewicz-Kwilecki, I. M., and Pappas, B. A., 1974, 6-Hydroxydopamine sympathectomy in the neonatal rat—effects on brain serotonin and histamine, Biochem. Pharmacol. 23: 2395–2401.
Peterson, D. W., and Sparker, S. B., 1973, Increased fixed ratio response rates following norepinephrine depletion by 6-hydroxydopamine (6-HDA), Fed. Proc. 32: 753.
Pieri, L., Pieri, M., and Haefely, W., 1974, LSD as an agonist of dopamine receptors in the striatum. Nature (London) 252: 586–588.
Pijnenburg, A.J.J., Honig, W.M.M., Van Rossum, J. M., 1975, Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats, Psychopharmacologia 41: 175–180.
Plech, A., Herman, Z. S., Wierzbicki, A., 1975a, Role of the noradrenergic and the dopaminergic receptors in the mechanism of the avoidance reflex in rats, Acta Med. Pol. 16: 225–230.
Plech, A., Herman, Z. S., Brus, R., and Drybanski, A., 1975b, The impairment of learning of conditioned avoidance response in rats after 6-hydroxydopamine, Acta Nerv. Super. 17: 176–178.
Pletscher, A., 1966, Monoamine oxidase inhibitors, Pharmacol. Rev. 18: 121–129.
Pletscher, A., and Bartholini, G., 1971, Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation, Clin. Pharmacol. Therap. 12: 344–352.
Pohorecky, L. A., Zigmond, M., Karten, H., and Wurtman, R. J., 1969, Enzymatic conversion of norepinephrine to epinephrine by the brain, J. Pharmacol. Exp. Tiler. 165: 190–195.
Poirier, L. J., 1975, Histopathological changes associated with the intracerebral injection of 6-hydroxydopamine (6-OHDA) and peroxide (F1202) in the cat and rat, J. Neural Transmission 37: 209–218.
Poirier, L. J., Singh, P., Sourkes, T. L., and Boucher, R., 1967, Effect of amine precursors on the concentration of striatal dopamine and serotonin in cats with and without unilateral brain stem lesions, Brain Res. 6: 654–666.
Poirier, L. J., Langelier, P., Roberge, A. G., Boucher, R., and Kitsikis, A., 1972, Non-specific histophathological changes induced by the intracerebral injection of 6-hydroxydopamine (6-OHDA), J. Neurol. Sci. 16: 401–416.
Porter, C. C., Watson, L. S., Titus, D. C., Totaro, J. A., and Byer, S. S., 1962, Inhibition of dopa decarboxylase by the hydrozino analog of a-methyl dopa, Biochem. Pharmacol. 11: 1067–1077.
Posluns, D., 1962, An analysis of chlorpromazine-induced suppression of the avoidance response, Psychopharmacologia 3: 361–373.
Powell, B. J., 1970, The role of d-amphetamine-amobarbital in suppressing freezing behavior during avoidance acquisition and extinction, Psychol. Rec. 20: 101–105.
Price, M.T.C., and Fibiger, H. C., 1974, Apomorphine and amphetamine stereotypy after 6- hydroxydopamine lesions of the substantia nigra, Eur. J. Pharmmcol. 29: 249–252.
Price, M. T., and Fibiger, H. C., 1975, Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection, Pharmacol. Biochem. Behay. 3: 285–290.
Prichard, J. W., and Guroff, G., 1971, Increased cerebral excitability caused by p-chlorophenylalanine in young rats, J. Neurochem. 18: 153–160.
Rainbow, T. C., Adler, J. E., and Flexner, L. B., 1976, Comparison in mice of the amnesic effects of cycloheximide and 6-hydroxydopamine in a one-trial passive avoidance task, Pharmacol. Biochem. Behave. 4: 347–349.
Rake, A., 1973, Involvement of biogenic amines in memory formation: The central nervous system indole amine involvement, Psychopharmacologia 29: 91–100.
Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Pychopharmacologia 11: 300–310.
Randrup, A., and Munkvad, I., 1970, Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamines, in “Amphetamines and Related Compounds” (E. Costa and S. Garattini, eds.), Raven, New York.
Randt, C. T., Quartermain, D., Goldstein, M., and Anagnoste, G., 1971, Norepinephrine biosynthesis inhibition: Effects on memory in mice, Science 172: 498–499.
Ray, O. S., and Barrett, R. J., 1975, Behavioral, pharmacological and biochemical analysis of genetic differences in rats, Behay. Biol. 15: 391–417.
Rech, R. H., 1964, Antagonism of reserpine behavioural depression by d-amphetamine, J. Pharmacol. Exp. Ther. 146: 369–376.
Rech, R. H., 1966, Amphetamine effects on poor performance of rats in a shuttlebox, Psychopharmacologia 9: 110–117.
Rech, R. H., and Moore, K. E., 1968, Interactions between d-amphetamine and a-methyltyrosine in rat shuttle-box behaviour, Brain Res. 8: 398–400.
Rech, R. H., and Stolk, J. M., 1970, Amphetamine-drug interactions that relate brain catecholamines to behavior, in “Amphetamines and Related Compounds” (E. Costa and S. Garattini, eds.), Raven, New York.
Rech, R. H., Borys, H. K., and Moore, K. E., 1966, Alterations in behavior and brain catecholamine levels in rats treated with a-methyltyrosine, J. Ph armacol. Exp. Ther. 153: 412–419.
Rech, R. H., Tilson, H. A., and Marquis, W. J., 1975, Adaptive changes in behavior after repeated administration of various psychoactive drugs, in “Neurobiological Mechanisms of Adaptation and Behavior” (A. J. Mandell, ed.), Raven, New York; Adv. Biochem. Psychopharmacol. 13:263–286.
Reis, D. J., Joh, T. H., and Ross, R. A., 1975, Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-3-hydroxylase in catecholamine neuronal systems in rat brain, J. Pharmacol. Exp. Ther. 193: 775–784.
Remington, G., and Anisman, H., 1974, Disruptive effects of epinephrine on active avoidance behavior: Alteration by scopolamine and d-amphetamine, Pharmacol. Biochem. Behay. 2: 427–430.
Renson, J., 1973, Assays and properties of tryptophan 5-hydroxylase, in “Serotonin and Behavior” (J. Barchas and E. Usdin, eds.), pp. 19–32, Academic, New York.
Richardson, J. S., and Jacobowitz, D. M., 1973, Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: A biochemical histochemical and behavioral study in rats, Brain Res. 58: 117–133.
Robbins, T. W., and Iverson, S. D., 1973, Amphetamine-induced disruption of temporal discrimination by response disinhibition, Nature (London) New Biol. 245: 191–192.
Roberts, D.C.S., Zis, A. P., and Fibiger, H. C., 1975, Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent noninvolvement of norepinephrine, Brain Res. 93: 441–454.
Roberts, D.C.S., Price, M.T.C., and Fibiger, H. C., 1976, The dorsal tegmental noradrenergic projection: An analysis of its role in maze learning,,. Comp. Physiol. Psychol. 90: 363–372.
Robichaud, R., and Sledge, K., 1969, The effects of p-chlorophenylalanine on experimentally induced conflict in the rat, Life Sci. 8: 965–969.
Rolinski, Z., and Scheel-Druger, J., 1973, The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats, Acta Pharmacol. Toxicol. 33: 385–399.
Rosen, A. J., and LaFlore, J. E., and 1973, Effects of intraperitoneal and intraventricular d-amphetamine administration on active avoidance performance in the rat, Life Sci. 13: 1573–1580.
Rosengren, E., 1960, On the role of monoamine oxidase for the inactivation of dopamine,in brain. Acta Physiol. Scand. 49: 370–375.
Roth, R. H., Salzman, P. M., and Morgenroth, V. H., 1974, Noradrenergic neurons: Allosteric activation of hippocampal tyrosine hydroxylase by stimulation of the locus coeruleus, Biochem. Pharmacol. 23: 2779–2784.
Rubin, B., Piala, J. J., Burke, J. C., and Craver, B. N., 1964, A new potent and specific serotonin inhibitor (SQ 10643) 2’-(3-dimethylaminopropylthio) cinnamanilide hydrochloride: Antiserotonin activity on uterus and on gastrointestinal, vascular and respiratory systems of animals, Arch. Int. Pharmacodyn. 152: 132–143.
Ruiz, M., and Monti, J. M., 1972, Prevention of the haloperidol-induced blockade of a conditioned avoidance response by 1-dopa, Eur. J. Pharmacol. 20: 93–96.
Saari, M., and Pappas, B. A., 1973, Neonatal 6-hydroxydopamine sympathectomy reduces footshock induced suppression of water-licking in normotensive and hypertensive rats, Nature (London), New Biol. 244: 181–183.
Sachs, C., 1973, Development of the blood-brain barrier for 6-hydroxydopamine, J. Neurochem. 20: 1753–1760.
Sachs, C., and Jonsson, G., 1972, Degeneration of central noradrenaline neurons after 6hydroxydopamine in newborn animals, Res. Commun. Chem. Pathol. Pharmacol. 4: 203–220.
Sachs, C., and Jonsson, G., 1975a, Mechanisms of action of 6-hydroxydopamine, Biochem. Pharmacol. 24: 1–8.
Sachs, C., and Jonsson, G., 1975b, Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny, Brain Res. 99: 277–291.
Sanders-Bush, E., Bushing, J. A., and Sulser, F., 1972a, Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in brain, Eur. J. Pharmacol. 20: 385–388.
Sanders-Bush, E., Bushing, J. A., and Sulser, F., 1972b, p-Chloroamphetamine-inhibition of cerebral tryptophan hydroxylase, Biochem. PharmacoL 21: 1501–1510.
Sanders-Bush, E., Gallager, D. A., and Sulser, F., 1974, On the mechanism of brain 5Hydroxytryptamine depletion of p-chloroamphetamine and related drugs and the specificity of their actions, in “Advances in Biochemical Psychopharmacology” (E. Costa, G. L. Gessa, and M. Sandler, eds.), Vol. 10, pp. 185–194, Raven, New York.
Sansone, M., and Bovet, D., 1969, Effects of amphetamine on the decrement of performance in avoidance conditioning of guinea pigs, Psychopharmacologia 16: 234–239.
Satinder, K. P., 1970, Effects of electric shock, d-amphetamine sulphate and chlorpromzaine on factors of emotionality in inbred mice, J. Comp. Physiol. Psychol. 71: 448–452.
Satinder, K. P., 1971, Genotype-dependent effects of d-amphetamine sulphate and caffeine on escape-avoidance behavior of rats, J. Comp. Physiol. Psychol. 76: 359–364.
Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., and Kopin, I. J., 1968, 3-Methoxy-4-hydroxyphenylglycol sulphate in brain and cerebrospinal fluid, Biochem. Pharmacol. 17: 2006–2008.
Scheel-Kruger, J., 1971, Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain, Eur. J. Pharmacol. 14: 47–59.
Scheuer, C., and Moore, N. J., 1974, Breakdown of stimulus control by d-amphetamine, Physiol. Psychol. 2: 427–430.
Schnaitman, C., Erwin, V. G., and Greenawalt, J. W., 1967, The submitochondrial localization of monoamine oxidase. An enzymatic marker for the outer membrane of rat liver mitochondria, J. Cell. Biol. 32: 719–735.
Schoenfeld, R. I., and Seiden, L. S., 1969, Effect of a-methyltyrosine on operant behavior and brain catecholamine levels, J. Pharmacol. Exp. Ther. 167: 319–326.
Schuster, C. R., and Zimmerman, J., 1961, Timing behavior during prolonged treatment with dl-amphetamine, J. Exp. Anal. Behay. 4: 327–330.
Schuster, C. R., Dockens, W. S., and Woods, J. H., 1966, Behavioral variables affecting the development of amphetamine tolerance, Psychopharmacologia 9: 170–182.
Scotti De Carolis, A., Ziegler, H., Del Basso, P., and Longo, V. G., 1971, Central effects of 6-hydroxydopamine, Physiol. Behay. 7: 705–708.
Seeman, P., and Lee, T., 1975, Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons, Science 188: 1217–1219.
Segal, D. S., 1975, Behavioral and neurochemical correlates of repeated d-amphetamine administration, in “Neurobiological Mechanisms of Adaptation and Behavior” (A. J. Mandell, ed.), Raven, New York.
Segal, D. S., and Mandell, A.J., 1974, Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy, Pharm. Biochem. Behay. 2: 249–255.
Segal, D. S., Sullivan, J. L., Kuczenski, R. T., and Mandell, A. J., 1971, Effects of long-term reserpine treatment on brain tyrosine hydroxylase and behavioral activity, Science 173: 847–849.
Seiden, L. S., 1976, The role of catecholamines in the action of drugs affecting behavior, Pharmacol. Ther. 2: 155–165.
Seiden, L. S., and Carlsson, A., 1963, Temporary and partial antagonism by L-DOPA of reserpine-induced suppression of conditioned avoidance response, Psychopharmacologia 4: 418–423.
Seiden, L. S., and Carlsson, A., 1964, Brain and heart catecholamine levels after L-DOPA administration in reserpine treated mice: Correlations with a conditioned avoidance response, Psychopharmacologia 5: 178–181.
Seiden, L. S., and Hanson, L.C.F., 1964, Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA, Psychopharmacologia 6: 239–244.
Seiden, L. S., and Peterson, D. D., 1968, Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-DOPA: Correlation of behavioral and biochemical differences in two strains of mice, J. Pharmacol. Exp. Ther. 159: 422–428.
Seliger, D. L., 1975, Dose response effects of d-amphetamine on passive avoidance learning in the rat, Psychopharmacologia 44: 191–193.
Senoh, S., Daly, J., Axelrod, J., and Witkop, B., 1959, Enzymatic p-O-methylation by catechol 0-methyl transferase, J. Am. Chem. Soc. 81: 6240–6245.
Seller, P., Saran, H., and McKenzie, G., 1976, Differential attenuation of some effects of haloperidol in rats given scopolamine, Eur. J. Pharmacol. 39: 117–126.
Sharman, D. F., 1963, A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue, Br. J. Pharmacol. Chemother. 20: 204–213.
Sharman, D. F., 1969, Glycol metabolites of noradrenaline in brain tissue, Br. J. Pharmacol. 36: 523–534.
Sharman, D. F., 1973, The catabolism of the catecholamines. Recent studies, Br. Med. Bull. 29: 110–115.
Shaywitz, B. A., Yager, R. D., and Klopper, J. H., 1976, Selective main dopamine depletion in developing rats: An experimental model of minimal brain dysfunction, Science 191: 305–307.
Sheard, M. H., 1974, The effect of p-chloroamphetamine on single raphé neurons, Adv. Biochem. Psychopharmacol. 10: 179–184.
Sheard, M. H., Zolovick, A., and Aghajanian, G. K., 1972, Raphé neurons: Effect of tricyclic antidepressant drugs, Brain Res. 43: 690–694.
Shettleworth, S. J., 1972, Constraints on learning, in “Advances in the Study of Behavior” (D. S. Lehrman, R. A. Hinde and E. Shaw, Eds.), Vol. 4, Academic, New York.
Shields, P. J., and Eccleston, D., 1972, Effects of electrical stimulation of rat midbrain on 5hydroxytryptamine synthesis as determined by a sensitive radioisotope method, J. Neurochem. 19: 265–272.
Shields, P. J., and Eccleston, D., 1973, Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain, J. Neurochem. 20: 881–888.
Sims, K. L., and Bloom, F. E., 1973, Rat brain L-3, 4-dihydroxyphenylalanine and 5hydroxytryptophan decarboxylase activities: Differential effect of 6-hydroxydopamine, Brain Rec. 49: 165–175.
Sims, K. L., Davis, G. A., and Bloom, F. E., 1973, Activities of 3,4-dihydroxy-c-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: Assay characteristics and distribution, J. Neurochem. 20: 449–464.
Singh, B., and De Champlain, J., 1972, Altered ontogenesis of central noradrenergic neurons following neonatal treatment with 6-hydroxydopamine, Brain Res. 48: 432–437.
Smith, A. D., 1972, Subcellular localization of noradrenaline in sympathetic neurons, Pharmacol. Rev. 24: 435–457.
Smith, R. D., Cooper, B. R., and Breese, G. R., 19.73, Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: Evidence for involvement of brain dopamine, J. Pharrnacol. Exp. Ther. 185: 609–619.
Smith, G. P., Levin, B. E., and Ervin, G. N., 1975, Loss of active avoidance responding after lateral hypothalamic injections of 6-hydroxydopamine, Brain Res. 88: 483–498.
Sorenson, C. A., and Ellison, G. D., 1973, Nonlinear changes in activity and emotional reactivity scores following central noradrenergic lesions in rats, Psychopharmacologia 32: 313–325.
Sorimachi, M., 1975, Increase of tyrosine hydroxylase activity after reserpine: Evidence for the selective response of noradrenergic neurons, Brain Res. 99: 400–404.
Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, Blockade of endogenous norepinephrine synthesis by a-methyl-tyrosine, an inhibitor of tyrosine hydroxylase, J. Pharmacol. Exp. Ther. 147: 86–95.
Srebro, B., and Lorens, S. A., 1975, Behavioral effects of selective midbrain raphé lesions in the rat, Brain Res. 89: 303–325.
Stark, P., and Fuller, R. W., 1972, Behavioral and biochemical effects of p-chlorophenylalanine, 3-chlorotyrosine and 3-chlorotyramine. A proposed mechanism for inhibition of self-stimulation, Neuropharmacology 11: 261–272.
Stark, P., Fuller, R. W., Hartley, L. W., Schaffer, R. J., and Turk, J. A., 1970, Dissociation of the effects of p-chlorophenylalanine on self-stimulation and on brain serotonin, Life Sci. 9 (1): 41–48.
Stein, L., Wise, C. D., and Berger, B. D., 1973, Antianxiety action of benzodiazepines: Decrease in activity of serotonin neurons in the punishment system, in “The Benzodiazepines” (S. Garattini, E. Mussini and L. O. Randall, eds.), pp. 299–326, Raven, New York.
Stein, L., Belluzzi, J. D., and Wise, C. D., 1975, Memory enhancement by central administration of norepinephrine, Brain Res. 84: 329–335.
Steranka, L. R., and Barrett, R.J., 1974, Facilitation of avoidance acquisition by lesion of the median raphé nucleus: Evidence for serotonin as a mediator of shock-induced suppression, Behay. Biol. 11: 205–213.
Stern, W. C., and Morgane, P. J., 1973, Effects of a-methyl tyrosine on REM sleep and brain amine levels in the cat, Biol. Psychiat. 6: 301–306.
Stern, W. C., Hartmann, E. L., Draskoczy, P. R., and Schildkraut, J. L., 1972, Behavioral effects of centrally administered 6-hydroxydopamine, Psvchol Rep. 30: 815–820.
Stevens, D. A., and Fechter, L. D., 1969, The effects of p-chlorophenylalanine, a depletor of brain serotonin, on behavior: II. Retardation of passive avoidance learning, Life Sci. 8: 379–385.
Stjarne, L., and Lishajko, F., 1967, Localization of different steps in noradrenaline synthesis to different fractions of bovine splenic nerve homogenate, Biochem. Pharmacol. 16: 1719–1728.
Stolk, J. M., and Rech, R. H., 1970, Antagonism of d-amphetamine by alpha-methyl-Ltyrosine: Behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response, Neuropharmacology 9: 249–263.
Stone, C. A., Wenger, H. C., Ludden, C. T., Stavorski, J. M., and Ross, C. A., 1961, Antiserotonin-antihistaminic properties of cyproheptadine, J. Pharmacol. Exp. Ther. 131: 73–84.
Strömberg, U., and Svensson, T. H., 1971, L-DOPA induced effects on motor activity in mice after inhibition of dopamine-ß-hydroxylase, Psychopharmacologia 19: 53–60.
Strömberg, U., Svensson, T. H., and Waldeck, B., 1970, On the mode of action of amantadine, J. Pharm. Pharmacol. 22: 959–962.
Strömbom, U., 1975, Effects of low doses of catecholamine receptor agonists on exploration in mice, J. Neural Transmission 37: 229–235.
Strömbom, U., 1976, Catecholamine receptor agonists (effects on motor activity and rate of tyrosine hydroxylation in mouse brain), Naunyn. Schiedelberg’s Arch. Pharmacol. 292: 167–176.
Svensson, T. H., 1973, Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine-ß-hydroxylase inhibitor, J. Pharm. Pharmacol. 25: 73–75.
Svensson, T., and Waldeck, B., 1969, On the significance of central noradrenaline for motor activity: Experiments with a new dopamine-ß-hydroxylase inhibitor, Eur. J. Pharmacol. 7: 278–282.
Svensson, T. H., and Waldeck, B., 1970, On the role of brain catecholamines in motor activity experiments with inhibitors of synthesis and monoamine oxidase, Psychopharmacologia 18: 357–365.
Swanson, L. W., and Hartman, B. K., 1975, The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-ß-hydroxylase as a marker, J. Comp. Neurol. 163: 467–506.
Sweig, R., McLean, J. H., Kostrzewa, R. M., and May, J. G., 1975, Behavioral and Biochemical Effects of Neonatal 6-Hydroxydopa Injections, paper presented at Society for Neuroscience 5th Annual Meeting, New York.
Swonger, A. K., and Rech, R. H., 1972, Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y-maze, J. Comp. Physiol. Psychol. 81:509.-522.
Swonger, A. K., Chambers, W. F., and Rech, R. H., 1970, The effects of alterations in brain 5-HT on habituation of the cortical evoked response and the startel response in rats, The Pharmacologist 12: 207.
Symchowicz, S., Korduba, C. A., and Veals, J., 1973, The effect of amantadine on radiolabelled biogenic amines in the rat brain, Eur. J. Pharmacol. 21: 155–160.
Tabakoff, B., and Erwin, V. G., 1970, Purification and characterization of a reduced nicotinamide adenine dinucleotide phosphate-linked aldehyde reductase from brain, J. Biol. Chem. 245: 3263–3268.
Tagliamonte, A., Biggio, G., Vargiu, L., and Gessa, G. L., 1973, Free tryptophan in serum controls brain tryptophan level and serotonin synthesis, Life Sci. 12 (II): 227–287.
Tanaka, C., Yuh, Y., and Takaori, S., 1972, Relationship between brain monoamine levels and Sidman avoidance behavior in rats treated with tyrosine and tryptophan hydroxylase inhibitors, Brain Res. 45: 186–194.
Tanaka, C., Inagaki, C., and Fujiwara, H., 1976, Labelled noradrenaline release from rat cerebral cortex following electrical stimulation of locus coeruleus, Brain Res. 106: 384–389.
Taylor, K. M., and Laverty, R., 1972, The effects of drugs on the behavioral and biochemical actions of intraventricular 6-hydroxydopamine, Eur. J. Pharmacol. 17: 16–24.
Taylor, K. M., Clark, D. W. J., Laverty, R., and Phelan, E. L., 1972, Specific noradrenergic neurons destroyed by 6-hydroxydopamine injection into newborn rats, Nature (London), New Biol. 239: 247–248.
Tenen, S., 1967, The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat, Psychopharmacologia 10: 204–219.
Thierry, A. M., Blanc, G., Sobel, A., Stinus, L., and Glowinski, J., 1973, Dopamine terminals in the rat cortex, Science 182: 499–501.
Thoa, N. B., Eichelman, B., Richardson, J. S., and Jacobowitz, D., 1972, 6-hydroxydopa depletion of brain norepinephrine and the facilitation of aggressive behavior, Science 178: 75–77.
Thoenen, H., Kettler, R., Burkard, W., and Saner, A., 1971, Neurally mediated control of enzymes involved in the synthesis of norepinephrine: Are they regulated as an operational unit?, Naunyn Schmicdclberg’s Arch. Pharmacol. 270: 146–160.
Thornburg, J. E., and Moore, K. E., 1971, Stress-related effects of various inhibitors of catecholamine synthesis in the mouse, Arch. Int. Pharmacodvn. 194: 158–167.
Thornburg, J. E., and Moore, K. E., 1973, The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs, Neuropharmacolov 12: 853–866.
Thornburg, J. E., and Moore, K. E., 1975, Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice, J. Pharmacol. Exp. Ther. 192: 42–49.
Thornton, E. W., Goudie, A. J., and Bithell, V., 1975, The effects of neonatal 6-hydroxydopamine induced sympathectomy on response inhibition in extinction, Life Sci. 17: 363–368.
Thut, P. D., 1974, Effect of L-dopa and L-dopa analogues on Sidman avoidance performance in mice, The Pharmacologist 16: 307.
Tilson, H. A., and Rech, R. H., 1973a, Prior drug experience and effects of amphetamine on schedule controlled behavior, Pharmacol. Biochem. Behan. 1: 129–132.
Tilson, H. A., and Rech, R. H., 1973b, Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity, Pharmacol. Biochem. Behay. 1: 149–153.
Tilson, H. A., Maisel, A. S., Jourdan, M. G., and Rech, R. H., 1976, Comparison of the effects of d-amphetamine and lysergic acid diethylamide in two strains of rats having different behavioral baselines, Behay. Biol. 17: 463–471.
Tozer, T. N., Neff, N. H., and Brodie, B. B., 1966, Application of steady state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpinetreated rats, J. Pharmacol. Exp. Ther. 153: 177–182.
Trulson, M. E., and Jacobs, B. L., 1976, Dose—response relationships between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphé unit activity in the rat, Neuropharmacology 15: 339–344.
Turner, A. J., and Tipton, K. F., 1972, The purification and properties of an NADPHlinked aldehyde reductase from pig brain, Eur. J. Biochem. 30: 361–368.
Udenfriend, S., Witkop, B., Redfield, B. G., and Weissbach, H., 1958, Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds, Biochem. Pharmacol. 1: 160–165.
Udenfriend, S., Zaltzman-Nirenberg, P., and Nagatsu, T., 1965, Inhibitors of purified beef adrenal tyrosine hydroxylase, Biochem. Pharmacol. 14: 837–845.
Ungerstedt, U., 1971, Stereotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol, Scand. Suppl. 367: 1–48.
Uretsky, N. J., and Iversen, L. L., 1970, Effects of 6-hydroxydopamine on catecholamine containing neurons in the rat brain, J. Neurochem. 17: 269–278.
Van Zwieten-Boot, B. J., and Noach, E. L., 1975, The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat, Eur. J. Pharmacol. 33: 247–254.
Verhave, T., 1958, The effect of methamphetamine on operant level and avoidance behavior, J. Exp. Anal. Behay. 1: 207–219.
von Hungen, K., Roberts, S., and Hill, D. F., 1974, LSD as an agonist and antagonist at central dopamine receptors, Nature (London) 252: 588–589.
VonVoigtlander, P. F., Losey, E. G., Triezenberg, H. J., 1975, Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment, J. Pharmacol Exp. Ther. 193: 88–94.
Wallach, M. B., 1974, Drug-induced stereotyped behavior: Similarities and differences, in “Neuropsychopharmacology of Monoamines and their Regulatory Enzymes” (E. Usdin, ed.), Raven, New York.
Weiner, W. J., Goetz, C., Westheimer, R., and Klawans, H. L., Jr., 1973, Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior, J. Neurol. Sci. 20: 373–379.
Weiner, W. J., Goetz, C., and Klawans, H. L., 1975, Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour, Acta Pharmacol. Toxicol. 36: 155–160.
Weissman, A., 1967, Drugs and retrograde amnesia, Int. Rev. Neurobiol. 10: 167–198.
Weissman, A., 1973, Behavioral pharmacology of p-chlorophenylalanine (PCPA), in “Serotonin and Behavior” (I. Barchas and E. Usdin, eds.), pp. 235–248, Academic, New York.
Weissman, A., Koe, B. K., and Tenen, S. S., 1966, Antiamphetamine effects following inhibition of tyrosine hydroxylase, J. Pharmacol. Exp. Ther. 151: 339–352.
Welch, A. S., and Welch, B. L., 1968, Effects of stress and parahlorophenylanine upon brain serotonin, 5-hydroxyindoleacetic acid and catecholamines in grouped and isolated mice, Biochem. Pharmacol. 17: 699–708.
White, T. D., 1976, Evidence that the rapid binding of newly accumulated noradrenaline within synaptosomes involves synaptic vesicles, Brain Res. 108: 87–96.
White, T. D., and Keen, P., 1970, The role of internal and external Na+ and K+ on the uptake of [3H]-noradrenaline by synaptosomes prepared from rat brain, Biochem. Biophys. Acta 196: 285–295.
Whittaker, V. P., 1966, Catecholamine storage particles in the central nervous system, Pharmacol. Rev. 18: 401–412.
Williams, J. M., Hamilton, L. W., and Carlton, P. L., 1974, Pharmacological and anatomical dissociation of two types of habituation, J. Comp. Physiol. Psychol. 87: 724–732.
Williams, J. M., Hamilton,L. W., and Carlton, P. L., 1975, Ontogenetic dissociation of two classes of habituation, J. Comp. Physiol. Psychol. 89: 733–737.
Winokur, G., and Bagchi, S. P., 1974, Effects of bufotenine and p-chlorophenylalanine on reactivity to footshock, Physiol. Psychol. 2: 75–79.
Winokur, G., Bagchi, S. P., and Hubbard, P., 1971, Effects of bufotenine and p-chlorophenylalanine on stress induced behaviour, Psychopharmacologia 22: 100–110.
Wise, C. D., Berger, B. D., and Stein, L., 1970, Brain serotonin and conditioned fear, Proc. 78th Ann. Meet. Am. Psychol. Assoc. 5: 821–822.
Wong, D. T., Horng, J. S., and Fuller, R. W., 1973, Kinetics of serotonin accumulation into synaptosomes of rat brain—effects of amphetamine and chloroamphetamines, Biochem. Pharmacol. 22: 311–322.
Wright, D. C., 1974, Differentiating stimulus and storage hypotheses of state dependent learning, Fed. Proc. Fed. Am. Soc. Exp. Biol. 33: 1797–1799.
Yang, H.Y.T., and Neff, N. H., 1974, The monoamine oxidases of brain: Selective inhibition with drugs and the consequences for the metabolism of the biogenic amines, J. Pharmacol. Exp. Ther. 189: 733–740.
Yarbrough, G. G., 1975, Supersensitivity of caudate neurons after repeated administration of haloperidol, Eur. J. Pharmacol. 31: 367–369.
Zhelyaskov, D. K., Levitt, M., and Udenfriend, S., 1968, Tryptophan derivatives as inhibitors of tyrosine hydroxylase in vivo and in vitro, Mol. Pharmacol. 4: 445–451.
Ziance, R. J., Azzaro, A. J., and Rutledge, C.O., 1972, Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro, J. Pharmacol. Exp. Ther. 182: 284–294.
Zieher, L. M., and Jaim-Etcheverry, G., 1975, 6-hydroxydopa during development of central adrenergic neurons produces different long-term changes in rat brain noradrenaline, Brain Res. 86: 271–281.
Zigmond, M. J., and Sticker, E. M., 1972, Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats, Science, 177: 1211–1214.
Zis, A. P., Fibiger, H. C., and Phillips, A. G., 1974, Reversal by 1-DOPA of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection, Science 185: 960–962.
Zivkovic, B., Guidotti, A., and Costa, E., 1973, Increase of tryptophan hydroxylase activity elicited by reserpine, Brain Res. 57: 522–526.
Zornetzer, S. F., Gold, M. S., and Hendrickson, J., 1974, Alpha-methyl-p-tyrosine and memory: State-dependency and memory failure, Behay. Biol. 12: 135–141.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Peters, D.A.V., Anisman, H., Pappas, B.A. (1978). Monoamines and Aversively Motivated Behaviors. In: Anisman, H., Bignami, G. (eds) Psychopharmacology of Aversively Motivated Behavior. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2394-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2394-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2396-9
Online ISBN: 978-1-4684-2394-5
eBook Packages: Springer Book Archive